Edgar Filing: Nuance Communications, Inc.

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company

Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2012

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-27038

NUANCE COMMUNICATIONS, INC.

(Exact name of registrant as specified in its charter)


Delaware		94-3156479
(State or Other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

1 Wayside Road Burlington, Massachusetts		01803
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code:

(781) 565-5000

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares of the Registrant’s Common Stock, outstanding as of April 30, 2012, was 306,643,158.

NUANCE COMMUNICATIONS, INC.

TABLE OF CONTENTS


		Page

PART I: FINANCIAL INFORMATION
Item 1.	Consolidated Financial Statements (unaudited):
	a) Consolidated Statements of Operations for the three and six months ended March 31, 2012 and 2011		2
	b) Consolidated Balance Sheets at March 31, 2012 and September 30, 2011		3
	c) Consolidated Statements of Cash Flows for the six months ended March 31, 2012 and 2011		4
	d) Notes to Consolidated Financial Statements		5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		20
Item 3.	Quantitative and Qualitative Disclosures about Market Risk		35
Item 4.	Controls and Procedures		37

PART II: OTHER INFORMATION
Item 1.	Legal Proceedings		38
Item 1A.	Risk Factors		38
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		46
Item 3.	Defaults Upon Senior Securities		46
Item 4.	Mine Safety Disclosures		46
Item 5.	Other Information		46
Item 6.	Exhibits		46
Signatures			47
Exhibit Index			48
Certifications

NUANCE COMMUNICATIONS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS


	Three Months Ended March 31,						Six Months Ended March 31,
	2012			2011			2012			2011
	(Unaudited)
	(In thousands, except per share amounts)
Revenues:
Product and licensing	$	176,466		$	141,580		$	341,200		$	275,436
Professional services and hosting		155,535			128,911			295,117			251,731
Maintenance and support		58,340			48,471			114,667			95,624

Total revenues		390,341			318,962			750,984			622,791

Cost of revenues:
Product and licensing		17,691			14,984			36,455			32,130
Professional services and hosting		97,221			86,490			187,375			164,702
Maintenance and support		10,893			9,536			21,913			17,809
Amortization of intangible assets		14,867			14,163			29,801			27,454

Total cost of revenues		140,672			125,173			275,544			242,095

Gross profit		249,669			193,789			475,440			380,696

Operating expenses:
Research and development		53,992			46,272			106,046			87,653
Sales and marketing		84,354			74,137			174,751			152,481
General and administrative		41,149			37,188			72,464			68,370
Amortization of intangible assets		21,905			21,572			45,108			44,249
Acquisition-related costs, net		14,986			2,314			29,597			5,315
Restructuring and other charges, net		2,536			2,428			5,400			4,479

Total operating expenses		218,922			183,911			433,366			362,547

Income from operations		30,747			9,878			42,074			18,149
Other income (expense):
Interest income		648			659			1,241			1,486
Interest expense		(19,951	)		(8,838	)		(37,671	)		(18,065	)
Other income, net		913			2,423			6,644			8,564

Income before income taxes		12,357			4,122			12,288			10,134
Provision for income taxes		11,467			2,387			2,058			8,408

Net income	$	890		$	1,735		$	10,230		$	1,726

Net income per share:
Basic	$	0.00		$	0.01		$	0.03		$	0.01

Diluted	$	0.00		$	0.01		$	0.03		$	0.01

Weighted average common shares outstanding:
Basic		305,282			300,937			304,643			299,772

Diluted		322,642			314,756			321,792			313,152

See accompanying notes.

NUANCE COMMUNICATIONS, INC.

CONSOLIDATED BALANCE SHEETS


	March 31, 2012			September 30, 2011
	(Unaudited)
	(In thousands, except per share amounts)
ASSETS
Current assets:
Cash and cash equivalents	$	966,740		$	447,224
Restricted cash (Note 9)		—			6,799
Marketable securities		10,109			31,244
Accounts receivable, less allowances for doubtful accounts of $6,464 and $5,707		316,498			280,856
Prepaid expenses and other current assets		84,823			88,804

Total current assets		1,378,170			854,927
Land, building and equipment, net		99,630			78,218
Goodwill		2,411,320			2,347,880
Intangible assets, net		693,888			731,577
Other assets		124,226			82,691

Total assets	$	4,707,234		$	4,095,293


LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt and capital leases	$	149,342		$	6, 905
Redeemable convertible debentures		227,131			—
Contingent and deferred acquisition payments		41,358			23,783
Accounts payable		98,292			82,703
Accrued expenses and other current liabilities		148,905			176,074
Deferred revenue		212,546			185,605

Total current liabilities		877,574			475,070
Long-term portion of debt and capital leases		1,027,444			853,020
Deferred revenue, net of current portion		100,845			90,382
Deferred tax liability		73,437			72,229
Other liabilities		100,342			111,221

Total liabilities		2,179,642			1,601,922

Commitments and contingencies (Notes 5 and 17)
Equity component of currently redeemable convertible debentures (Note 12)		22,869			—

Stockholders’ equity:
Series B preferred stock, $0.001 par value; 15,000 shares authorized; 3,562 shares issued and outstanding (liquidation preference $4,631)		4,631			4,631
Common stock, $0.001 par value; 560,000 shares authorized; 310,114 and 312,456 shares issued and 306,364 and 308,705 shares outstanding		310			312
Additional paid-in capital		2,870,500			2,745,931
Treasury stock, at cost (3,751 and 3,751 shares)		(16,788	)		(16,788	)
Accumulated other comprehensive income		4,130			2,402
Accumulated deficit		(358,060	)		(243,117	)

Total stockholders’ equity		2,504,723			2,493,371

Total liabilities and stockholders’ equity	$	4,707,234		$	4,095,293

See accompanying notes.

NUANCE COMMUNICATIONS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS


	Six Months Ended March 31,
	2012			2011
	(Unaudited)
	(In thousands)
Cash flows from operating activities:
Net income	$	10,230		$	1,726
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		90,290			84,723
Stock-based compensation		70,808			75,717
Non-cash interest expense		16,064			6,369
Deferred tax (benefit) provision		(11,230	)		564
Other		1,412			700
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable		(34,298	)		(2,519	)
Prepaid expenses and other assets		(4,149	)		(11,196	)
Accounts payable		15,841			(1,446	)
Accrued expenses and other liabilities		(2,963	)		(31,035	)
Deferred revenue		38,048			35,845

Net cash provided by operating activities		190,053			159,448

Cash flows from investing activities:
Capital expenditures		(37,775	)		(16,564	)
Payments for business and technology acquisitions, net of cash acquired		(126,833	)		(17,523	)
Purchases of marketable securities		—			(10,776	)
Proceeds from sales and maturities of marketable securities		20,759			6,650
Change in restricted cash balances		6,747			17,184

Net cash used in investing activities		(137,102	)		(21,029	)

Cash flows from financing activities:
Payments of debt and capital leases		(3,606	)		(4,091	)
Proceeds from issuance of convertible debt, net of issuance costs		676,317			—
Payments for repurchases of common stock		(199,997	)		—
Proceeds from (payments for) settlement of share-based derivatives		9,020			(628	)
Payments of other long-term liabilities		(5,391	)		(5,274	)
Excess tax benefits on employee equity awards		7,000			4,020
Proceeds from issuance of common stock from employee stock plans		17,431			14,611
Cash used to net share settle employee equity awards		(36,139	)		(26,426	)

Net cash provided by (used in) financing activities		464,635			(17,788	)

Effects of exchange rate changes on cash and cash equivalents		1,930			4,451

Net increase in cash and cash equivalents		519,516			125,082
Cash and cash equivalents at beginning of period		447,224			516,630

Cash and cash equivalents at end of period	$	966,740		$	641,712

See accompanying notes.

NUANCE COMMUNICATIONS, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1.	Organization and Presentation

The consolidated financial statements include the accounts of Nuance Communications, Inc. (“Nuance”, “we”, or “the Company”) and our wholly-owned subsidiaries. We prepared these unaudited interim consolidated financial statements in accordance with U.S. generally accepted accounting principles (GAAP) for interim periods. In our opinion, these financial statements reflect all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of our financial position for the periods disclosed. Intercompany transactions have been eliminated.

Although we believe the disclosures in these financial statements are adequate to make the information presented not misleading, certain information normally included in the footnotes prepared in accordance with GAAP has been omitted. Accordingly, these financial statements should be read in conjunction with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2011. Interim results are not necessarily indicative of the results that may be expected for a full year.

2.	Summary of Significant Accounting Policies

We have made no material changes to the significant accounting policies disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2011. There have been no significant changes to the new accounting pronouncements that were disclosed in our Annual Report.

Certain prior year balances have been reclassified to conform to the current period’s presentation. Such reclassifications did not affect total assets, total liabilities, total revenues, operating income or net income.

3.	Comprehensive Income

The components of comprehensive income are as follows (dollars in thousands):


	Three Months Ended March 31,					Six Months Ended March 31,
	2012			2011		2012			2011
Net income	$	890		$	1,735	$	10,230		$	1,726
Other comprehensive income:
Foreign currency translation adjustment		16,479			18,416		1,674			16,745
Unrealized (loss) gain on cash flow hedge derivatives		(20	)		12		(20	)		519
Unrealized gain (loss) on marketable securities, net		6			77		4			(2	)
Recognition of pension loss amortization		24			89		70			130

Other comprehensive income		16,489			18,594		1,728			17,392

Comprehensive income	$	17,379		$	20,329	$	11,958		$	19,118

4.	Business Acquisitions

Fiscal 2012 Acquisitions

Acquisition of Transcend

In March 2012, we signed an agreement to acquire Transcend Services, Inc. Under the terms of the agreement, we agreed to acquire Transcend pursuant to a cash tender offer for all the outstanding shares of Transcend at a price of $29.50 per share. On April 26, 2012, we purchased 10,444,598 shares at $29.50 per share for a total purchase price of $308.1 million. We have not yet completed our fair value analysis of assets and liabilities acquired, and therefore it is impractical to prepare pro forma information about revenue and earnings as if we had acquired Transcend on October 1, 2010.

Acquisition of Swype

On October 6, 2011, we acquired all of the outstanding capital stock of Swype, Inc. (“Swype”), a provider of software that allows users to type by sliding a finger or stylus from letter to letter, which will be reported in our Mobile and Consumer segment. Total consideration for the purchase was approximately $102.5 million, of which $77.5 million was paid in cash at the closing and the remaining $25.0 million (the “Contingent Consideration”) is payable on the eighteen-month anniversary of the closing. The Contingent Consideration is subject to certain adjustments and conditions, including the requirement that certain key executives not terminate their employment with Nuance or have their employment terminated for certain reasons. The goodwill resulting from this acquisition is not expected to be deductible for tax purposes. The results of operations of Swype have been included in our results of operations from the acquisition date.

A summary of the preliminary allocation of the purchase consideration for Swype is as follows (dollars in thousands):


Total purchase consideration:
Cash	$	77,500
Fair value of contingent consideration		16,444

Total purchase consideration	$	93,944

Allocation of the purchase consideration:
Cash	$	6,741
Accounts receivable		3,420
Goodwill		64,579
Identifiable intangible assets(a)		32,300
Other assets		264

Total assets acquired		107,304
Current liabilities		(706	)
Deferred tax liability		(12,654	)

Total liabilities assumed		(13,360	)

Net assets acquired	$	93,944

(a)	The following are the identifiable intangible assets acquired and their respective weighted average useful lives, as determined based on preliminary valuations (dollars in thousands):


	Amount		Weighted Average Life (Years)
Core and completed technology	$	16,500		7.0
Customer relationships		10,800		10.0
Trade name		4,800		8.0
Non-Compete agreement		200		3.0

Total	$	32,300

Fiscal 2011 Acquisitions

On June 15, 2011, we acquired all of the outstanding capital stock of Equitrac, a leading provider of print management solutions, to expand the offerings of our Imaging segment, for cash consideration of approximately $162.0 million. The acquisition was a stock purchase and the goodwill resulting from this acquisition is not expected to be deductible for tax purposes. The results of operations of Equitrac have been included in our results of operations from the acquisition date.

On June 16, 2011, we acquired all of the outstanding capital stock of SVOX, a Swiss based seller of speech recognition, dialog, and text-to-speech software products for the automotive, mobile and consumer electronics industries in our Mobile and Consumer segment. Total purchase consideration was €87.0 million which consists of cash consideration of €57.0 million ($80.9 million based on the exchange rate as of the date of acquisition) and a deferred acquisition payment of €30.0 million ($43.0 million based on the exchange rate as of the date of acquisition). The deferred acquisition payment is payable in cash or shares of our common stock, at our option; €8.3 million of the deferred acquisition payment is due on June 16, 2012 and the remaining €21.7 million is due on December 31, 2012. The acquisition was a stock purchase and the goodwill resulting from this acquisition is not expected to be deductible for tax purposes. The results of operations of SVOX have been included in our results of operations from the acquisition date.

Pending Acquisition

In December 2011, we signed an agreement to acquire Vlingo, Inc., subject to regulatory approvals and other customary closing conditions. Pursuant to the terms of the agreement, we have advanced $30.0 million to Vlingo, which is reported in Other Assets at March 31, 2012. In the event that this transaction does not close by July 1, 2012, we are required to make an advance of $5.0 million, and will be obligated to pay an additional $5.0 million on the first day of each month thereafter, up to $30.0 million, until the transaction is completed. We will evaluate the recoverability of the advances each period until the acquisition is completed. Any portion of the advances deemed not recoverable will be expensed as acquisition-related costs, net. If the merger agreement is terminated and the transaction does not close, we will expense these non-refundable advances as acquisition-related costs, net.

Proforma Results

The following table shows unaudited pro forma results of operations as if we had acquired Equitrac, SVOX and Swype on October 1, 2010 (dollars in thousands, except per share amounts):


	Three Months Ended March 31,					Six Months Ended March 31,
	2012		2011			2012			2011
Revenue	$	390,341	$	338,047		$	750,984		$	659,857
Net income (loss)		890		(4,122	)		(1,449	)		(10,923	)
Net income (loss) per share	$	0.00	$	(0.01	)	$	(0.00	)	$	(0.04	)

We have not furnished pro forma financial information related to our other fiscal 2011 acquisitions because such information is not material, individually or in the aggregate, to our financial results. The unaudited pro forma results of operations are not necessarily indicative of the actual results that would have occurred had the transactions actually taken place at the beginning of the periods indicated.

Acquisition-Related Costs, net

Acquisition-related costs include those costs related to business and other acquisitions, including potential acquisitions. These costs consist of (i) transition and integration costs, including retention payments, transitional employee costs and earn-out payments treated as compensation expense, as well as the costs of integration-related services provided by third-parties; (ii) professional service fees, including third party costs related to the acquisition, and legal and other professional service fees associated with disputes and regulatory matters related to acquired entities; and (iii) adjustments to acquisition-related items that are required to be marked to fair value each reporting period, such as contingent consideration, and other items related to acquisitions for which the measurement period has ended.

The components of acquisition-related costs, net are as follows (dollars in thousands):


	Three Months Ended March 31,					Six Months Ended March 31,
	2012			2011		2012		2011
Transition and integration costs	$	2,844		$	96	$	6,213	$	1,053
Professional service fees		12,229			1,994		22,733		3,332
Acquisition-related adjustments		(87	)		224		651		930

Total	$	14,986		$	2,314	$	29,597	$	5,315

The increase in acquisition-related costs, net for the three and six months ended March 31, 2012, as compared to the three and six months ended March 31, 2011, was primarily driven by an increase in professional service fees incurred associated with the Vlingo and Transcend transactions, as well as post-acquisition legal and regulatory costs associated with recently completed acquisitions. For the three and six months ended March 31, 2012, transition and integration costs consisted primarily of the costs associated with transitional employees from our acquisition of Swype.

5.	Contingent Acquisition Payments

The fair value of any contingent consideration is established at the acquisition date and included in the total purchase price. The contingent consideration is then adjusted to fair value as an increase or decrease in current earnings included in acquisition-related costs, net in each reporting period.

In connection with our acquisition of Swype in October 2011, we agreed to make deferred payments to the former shareholders of Swype of up to $25.0 million in April 2013, contingent upon the continued employment of three named executives and certain other conditions. The contingent payments will be reduced by amounts specified in the merger agreement in the event that any of the three executives terminates employment prior to the payment date or if any losses occur to which we would be entitled to indemnification under the merger agreement. The portion of the deferred payment that is payable to the three named executives will be recognized as compensation expense over the 18 month employment period. The remaining liability has been recorded at its estimated fair value of $16.4 million.

In connection with an immaterial acquisition during fiscal 2010, we agreed to make contingent earn-out payments of up to $2.5 million, payable in stock, upon the achievement of certain financial targets for calendar year 2010 and 2011. At the acquisition date, we recorded $1.0 million as the fair value of the contingent consideration. For the six months ended March 31, 2012 and 2011, we have recorded expense of $0.7 million and $0.6 million, respectively, as fair value adjustments included in acquisition-related costs, net in our consolidated statement of operations. In September 2011, we paid $0.5 million in cash and stock to the former shareholders related to the calendar year 2010 earn-out.

In connection with our acquisition of Vocada, Inc. (“Vocada”) in November 2007, we agreed to make contingent earn-out payments of up to $21.0 million upon the achievement of certain financial targets measured over defined periods through December 31, 2010, in accordance with the merger agreement. We have notified the former shareholders of Vocada that the financial targets were not achieved. In December 2010, the former shareholders filed a demand for arbitration in accordance with their rights under the merger agreement. At March 31, 2012, we have not recorded any obligation related to these earn-out provisions.

6.	Goodwill and Intangible Assets

The changes in the carrying amount of goodwill and intangible assets for the six months ended March 31, 2012, are as follows (dollars in thousands):


	Goodwill			Intangible Assets
Balance as of September 30, 2011	$	2,347,880		$	731,577
Acquisitions		64,579			37,700
Purchase accounting adjustments		(1,744	)		—
Amortization		—			(74,909	)
Effect of foreign currency translation		605			(480	)

Balance as of March 31, 2012	$	2,411,320		$	693,888

7.	Financial Instruments and Hedging Activities

Derivatives Not Designated as Hedges

Forward Currency Contracts

We operate our business in countries throughout the world and transact business in various foreign currencies. Our foreign currency exposures typically arise from transactions denominated in currencies other than the local functional currency of our operations. During fiscal 2011, we commenced a program that primarily utilizes foreign currency forward contracts to offset these risks associated with the effect of certain foreign currency exposures. We commenced this program so that increases or decreases in our foreign currency exposures are offset by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with our foreign currency transactions. Generally, we enter into contracts for less than 90 days, and at March 31, 2012 we had outstanding contracts with a total notional value of $99.2 million.

We have not designated these forward contracts as hedging instruments pursuant to ASC 815, Derivatives and Hedging and accordingly, we recorded the fair value of these contracts at the end of each reporting period in our consolidated balance sheet, with changes in the fair value recorded in earnings as other income, net in our consolidated statement of operations.

Security Price Guarantees

From time to time we enter into agreements that allow us to issue shares of our common stock as part or all of the consideration related to partnering and technology acquisition activities. Generally these shares are issued subject to security price guarantees which are accounted for as derivatives. We have determined that these instruments would not be considered equity instruments if they were freestanding. The security price guarantees require payment from either us to a third party, or from a third party to us, based upon the difference between the price of our common stock on the issue date and an average price of our common stock approximately six months following the issue date. Changes in the fair value of these security price guarantees are reported in earnings in each period as other income, net. During the six months ended March 31, 2012 and 2011, we received (paid) cash amounts totaling $9.0 million and $(0.6) million, respectively, upon the settlement of agreements during the period.

The following table provides a quantitative summary of the fair value of our derivative instruments as of March 31, 2012 and September 30, 2011 (dollars in thousands):


		Fair Value
Description	Balance Sheet Classification	March 31, 2012			September 30, 2011
Derivatives Not Designated as Hedges:
Foreign currency contracts	Prepaid expenses and other current assets	$	63		$	—
Foreign currency contracts	Accrued expenses and other current liabilities	$	(747	)	$	(1,025	)
Security Price Guarantees	Prepaid expenses and other current assets		—			2,781

Net asset value of non-hedge derivative instruments		$	(684	)	$	1,756


Derivatives Designated as Hedges:
Foreign currency contracts	Prepaid expenses and other current assets	$	—		$	15

Net asset value of hedge derivative instruments		$	—		$	15

The following tables summarize the activity of derivative instruments for the three and six months ended March 31, 2012 and 2011 (dollars in thousands):

Derivatives Not Designated as Hedges


		Amount of Gain (Loss) Recognized in Income
	Location of Gain (Loss) Recognized in Income	Three Months Ended March 31,				Six Months Ended March 31,
	Location of Gain (Loss) Recognized in Income	2012		2011		2012		2011
Foreign currency contracts	Other income, net	$	731	$	2,223	$	99	$	(458	)
Security price guarantees	Other income, net	$	718	$	3,234	$	6,238	$	10,449

Derivatives Designated as Hedges for the Three Months Ended March 31,


	Amount of Gain (Loss) Recognized in OCI				Location and Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
	2012		2011			2012		2011
Foreign currency contracts	$	—	$	351	Other income, net	$	—	$	339

Derivatives Designated as Hedges for the Six Months Ended March 31,


	Amount of Gain (Loss) Recognized in OCI				Location and Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
	2012		2011			2012		2011
Foreign currency contracts	$	—	$	513	Other income, net	$	15	$	497
Interest rate swaps	$	—	$	—	Other income, net	$	—	$	(503	)

Other Financial Instruments

Financial instruments, including cash equivalents, restricted cash, marketable securities, accounts receivable, accounts payable, and derivative instruments, are carried in the consolidated financial statements at amounts that approximate their fair value.

The estimated fair value of our long-term debt approximated $1,784.1 million (face value $1,574.0 million) and $937.8 million (face value $887.4 million) at March 31, 2012 and September 30, 2011, respectively. These fair value amounts represent the value at which our lenders could trade our debt within the financial markets, and do not represent the settlement value of these long-term debt liabilities to us at each reporting date. The fair value of the long-term debt issues will continue to vary each period based on fluctuations in market interest rates, as well as changes to our credit ratings. The term loan portion of our Credit Facility is traded and the fair values were estimated using the averages of the March 31, 2012 and September 30, 2011 bid and ask trading quotes at each respective reporting date. The fair values of the 2.75% Convertible Debentures due 2027 and the 2.75% Convertible Debentures due 2031 at each respective reporting date were estimated using the averages of the bid and ask trading quotes. We had no outstanding balance on the revolving credit line portion of our Credit Facility at March 31, 2012 and September 30, 2011. Our capital lease obligations and other debt are not traded and the fair values of these instruments are assumed to approximate their carrying values as of March 31, 2012 and September 30, 2011.

8.	Fair Value Measures

Fair value is defined as the price that would be received for an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. Valuation techniques must maximize the use of observable inputs and minimize the use of unobservable inputs. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance.

ASC 820, Fair Value Measures and Disclosures, establishes a value hierarchy based on three levels of inputs, of which the first two are considered observable and the third is considered unobservable:

•

Level 1. Quoted prices for identical assets or liabilities in active markets which we can access.

•

Level 2. Observable inputs other than those described as Level 1.

•

Level 3. Unobservable inputs.

Assets and liabilities measured at fair value on a recurring basis at March 31, 2012 and September 30, 2011 consisted of (dollars in thousands):

		000000000		000000000		000000000		000000000
	March 31, 2012
	Level 1		Level 2		Level 3		Total

Assets:
Money market funds(a)	$	807,506	$	—	$	—	$	807,506
Time deposits(b)		—		50,249		—		50,249
US government agency securities(a)		1,000		—		—		1,000
Foreign currency exchange contracts(b)		—		63		—		63
Marketable securities, $10,123 at cost(b)		—		10,109		—		10,109

Total assets at fair value	$	808,506	$	60,421	$	—	$	868,927

Liabilities:
Foreign currency exchange contracts(b)	$	—	$	747	$	—	$	747
Contingent earn-out(d)		—		—		18,776		18,776

Total liabilities at fair value	$	—	$	747	$	18,776	$	19,523

		000000000		000000000		000000000		000000000
	September 30, 2011
	Level 1		Level 2		Level 3		Total

Assets:
Money market funds(a)	$	258,001	$	—	$	—	$	258,001
Time deposits(b)		—		49,832		—		49,832
US government agency securities(a)		1,000		—		—		1,000
Marketable securities, $31,256 at cost(b)		—		31,244		—		31,244
Foreign currency exchange contracts(b)		—		15		—		15
Security price guarantees(c)		—		2,781		—		2,781

Total assets at fair value	$	259,001	$	83,872	$	—	$	342,873

Liabilities:
Foreign currency exchange contracts(b)	$	—	$	1,025	$	—	$	1,025
Contingent earn-out(d)		—		—		1,358		1,358

Total liabilities at fair value	$	—	$	1,025	$	1,358	$	2,383

(a)	Money market funds and US government agency securities, included in cash and cash equivalents in the accompanying balance sheets, are valued at quoted market prices in active markets.

(b)

The fair values of our time deposits, marketable securities and foreign currency exchange contracts are based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable.

(c)

The fair values of the security price guarantees are determined using a modified Black-Scholes model, derived from observable inputs such as US treasury interest rates, our common stock price, and the volatility of our common stock. The valuation model values both the put and call components of the guarantees simultaneously, with the net value of those components representing the fair value of each instrument.

(d)

The fair value of our contingent consideration arrangements are determined based on our evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity, as well as our common stock price when the contingent consideration arrangement is payable in shares of our common stock. Refer to Note 5 for additional information.

The changes in the fair value of contingent earn-out liabilities are as follows (dollars in thousands):


	Three Months Ended March 31, 2012		Six Months Ended March 31, 2012
Balance at beginning of period	$	18,674	$	1,358
Earn-out liability established at time of acquisition		—		16,444
Charges to acquisition-related costs, net		102		974

Balance as of March 31, 2012	$	18,776	$	18,776

Earn-out payments are generally payable based on achieving the specified performance criteria during defined post-acquisition time periods as specified in the purchase and sale agreement for each acquisition. Changes in the fair value during the six months ended March 31, 2012 resulted from improved revenue performance together with an increase in our stock price during the earn-out period.

9.	Current Liabilities

Accrued expenses and other current liabilities consisted of the following (dollars in thousands):


	March 31, 2012		September 30, 2011
Compensation	$	71,611	$	97,929
Professional fees		17,814		11,975
Sales and marketing incentives(a)		10,745		16,253
Cost of revenue related liabilities		10,468		8,698
Sales and other taxes payable		9,624		9,876
Accrued interest payable		9,308		977
Acquisition costs and liabilities		5,231		8,414
Accrued business combination costs		3,302		8,275
Income taxes payable		2,867		4,240
Other		7,935		9,437

Total	$	148,905	$	176,074

(a)

Included in accrued sales and marketing incentives as of September 30, 2011, is a €5.0 million fixed obligation assumed in connection with our acquisition of SpinVox in 2009. At September 30, 2011, we had €5.0 million ($6.8 million equivalent) of restricted cash that has been placed in an irrevocable standby letter of credit related to the liability. The restricted cash was released upon the settlement of the liability during the three months ended December 31, 2011.

10.

Deferred Revenues

Deferred revenue consisted of the following (dollars in thousands):


	March 31, 2012		September 30, 2011
Current Liabilities:
Deferred maintenance revenue	$	109,977	$	101,480
Unearned revenue		102,569		84,125

Total current deferred revenue	$	212,546	$	185,605


Long-term Liabilities:
Deferred maintenance revenue	$	33,905	$	22,712
Unearned revenue		66,940		67,670

Total long-term deferred revenue	$	100,845	$	90,382

Deferred maintenance revenue consists of prepaid fees received for post-contract customer support for our products, including telephone support and the right to receive unspecified upgrades/enhancements on a when-and-if-available basis. Unearned revenue includes upfront fees for setup and implementation activities related to hosted offerings; certain software arrangements for which we do not have fair value of post-contract customer support, resulting in ratable revenue recognition for the entire arrangement on a straight-line basis; and fees in excess of estimated earnings on percentage-of-completion service contracts.

The increase in the deferred maintenance revenue is primarily related to an increase in Imaging maintenance and support. Unearned revenue increased as a result of billings in excess of revenues earned on professional service implementation projects.

11.

Restructuring and Other Charges, net

The following table sets forth accrual activity relating to restructuring and other charges for the six months ended March 31, 2012 (dollars in thousands):


	Personnel			Facilities			Total
Balance at September 30, 2011	$	5,121		$	940		$	6,061
Restructuring and other charges, net		4,715			658			5,373
Cash payments		(6,294	)		(1,036	)		(7,330	)

Balance at March 31, 2012	$	3,542		$	562		$	4,104

Restructuring and other charges, net by segment are as follows (dollars in thousands):

		00000		00000			00000		00000		00000		00000		00000		00000
	Three Months Ended March 31,
	2012									2011
	Personnel		Facilities			Other		Total		Personnel		Facilities		Other		Total
Healthcare	$	158	$	7		$	—	$	165	$	281	$	—	$	—	$	281
Mobile and Consumer		739		(207	)		—		532		672		—		—		672
Enterprise		616		—			—		616		1,124		—		—		1,124
Imaging		128		—			—		128		87		—		—		87
Corporate		1,014		—			—		1,014		197		99		93		389

Total	$	2,655	$	(200	)	$	—	$	2,455	$	2,361	$	99	$	93	$	2,553

		00000		00000		00000		00000		00000		00000		00000		00000
	Six Months Ended March 31,
	2012								2011
	Personnel		Facilities		Other		Total		Personnel		Facilities		Other		Total
Healthcare	$	442	$	61	$	—	$	503	$	299	$	—	$	—	$	299
Mobile and Consumer		1,313		597		—		1,910		817		—		—		817
Enterprise		1,282		—		—		1,282		1,487		1,263		—		2,750
Imaging		200		—		—		200		78		—		—		78
Corporate		1,478		—		—		1,478		350		99		93		542

Total	$	4,715	$	658	$	—	$	5,373	$	3,031	$	1,362	$	93	$	4,486

For the six months ended March 31, 2012, we recorded net restructuring and other charges of $5.3 million, which included a $4.7 million severance charge related to the elimination of approximately 140 personnel across multiple functions primarily to eliminate duplicative positions as a result of businesses acquired and a $0.6 million charge related to the elimination of redundant facilities assumed in connection with our acquisitions during fiscal 2012 and 2011.

12.

Credit Facilities and Debt

At March 31, 2012 and September 30, 2011, we had the following borrowing obligations (dollars in thousands):


	March 31, 2012		September 30, 2011
2.75% Convertible Debentures due 2027, net of unamortized discount of $22.9 million and $27.4 million, respectively	$	227,131	$	222,557
2.75% Convertible Debentures due 2031, net of unamortized discount of $147.3 million		542,740		—
Credit Facility		633,760		636,941
Obligations under capital leases and other		286		427

Total long-term debt		1,403,917		859,925
Less: current portion		376,473		6,905

Non-current portion of long-term debt	$	1,027,444	$	853,020

2.75% Convertible Debentures due 2031

ASC 470-20, Debt with Conversion and Other Options, requires us to allocate the proceeds to the liability component based on the fair value determined at the issuance date with the remainder allocated to the conversion right and recorded in stockholders’ equity. We initially allocated $533.6 million to long-term debt, and $156.4 million has been recorded as additional paid-in capital. The aggregate debt discount is being amortized to interest expense using the effective interest rate method through November 2017. The

2031 Debentures are general senior unsecured obligations and rank equally in right of payment with all of our existing and future unsecured, unsubordinated indebtedness and senior in right of payment to any indebtedness that is contractually subordinated to the 2031 Debentures. The 2031 Debentures will be effectively subordinated to indebtedness and other liabilities of our subsidiaries.

If converted, the principal amount of the 2031 Debentures is payable in cash and any amounts payable in excess of the $690 million principal amount, will (based on an initial conversion rate, which represents an initial conversion price of approximately $32.30 per share, subject to adjustment) be paid in cash or shares of our common stock, at our election, only in the following circumstances and to the following extent: (i) on any date during any fiscal quarter beginning after December 31, 2011 (and only during such fiscal quarter) if the closing sale price of our common stock was more than 130% of the then current conversion price for at least 20 trading days in the period of the 30 consecutive trading days ending on the last trading day of the previous fiscal quarter; (ii) during the five consecutive business-day period following any five consecutive trading-day period in which the trading price for $1,000 principal amount of the Debentures for each day during such five trading-day period was less than 98% of the closing sale price of our common stock multiplied by the then current conversion rate; (iii) upon the occurrence of specified corporate transactions, as described in the indenture for the 2031 Debentures; or (iv) at the option of the holder at any time on or after May 1, 2031. Additionally, we may redeem the 2031 Debentures, in whole or in part, on or after November 6, 2017 at par plus accrued and unpaid interest. Each holder shall have the right, at such holder’s option, to require us to repurchase all or any portion of the 2031 Debentures held by such holder on November 1, 2017, November 1, 2021, and November 1, 2026 at par plus accrued and unpaid interest. Upon conversion, we will pay the principal amount in cash and any amounts payable in excess of the $690 million principal amount will be paid in cash or shares of our common stock, at our election. If we undergo a fundamental change (as described in the indenture for the 2031 Debentures) prior to maturity, holders will have the option to require us to repurchase all or any portion of their debentures for cash at a price equal to 100% of the principal amount of the debentures to be purchased plus any accrued and unpaid interest, including any additional interest to, but excluding, the repurchase date. As of March 31, 2012, no conversion triggers were met. If the conversion triggers were met, we could be required to repay all or some of the principal amount in cash prior to the maturity date.

2.75% Convertible Debentures due 2027

We have $250 million of 2.75% convertible senior debentures due in August 2027 (the “2027 Debentures”). If converted, the principal amount of the 2027 Debentures is payable in cash and any amounts payable in excess of the $250 million principal amount, will (based on an initial conversion rate, which represents an initial conversion price of approximately $19.47 per share, subject to adjustment as defined therein) be paid in cash or shares of our common stock, at our election, only in the following circumstances and to the following extent: (i) on any date during any fiscal quarter beginning after September 30, 2007 (and only during such fiscal quarter) if the closing sale price of our common stock was more than 120% of the then current conversion price for at least 20 trading days in the period of the 30 consecutive trading days ending on the last trading day of the previous fiscal quarter; (ii) during the five consecutive business-day period following any five consecutive trading-day period in which the trading price for $1,000 principal amount of the Debentures for each day during such five trading-day period was less than 98% of the closing sale price of our common stock multiplied by the then current conversion rate; (iii) upon the occurrence of specified corporate transactions, as described in the indenture for the 2027 Debentures; and (iv) at the option of the holder at any time on or after February 15, 2027. Additionally, we may redeem the 2027 Debentures, in whole or in part, on or after August 20, 2014 at par plus accrued and unpaid interest. Each holder shall have the right, at such holder’s option, to require us to repurchase all or any portion of the 2027 Debentures held by such holder on August 15, 2014, August 15, 2017 and August 15, 2022 at par plus accrued and unpaid interest. Upon conversion, we will pay the principal amount in cash and any amounts payable in excess of the $250 million principal amount will be paid in cash or shares of our common stock, at our election. If we undergo a fundamental change (as described in the indenture for the 2027 Debentures) prior to maturity, holders will have the option to require us to repurchase all or any portion of their debentures for cash at a price equal to 100% of the principal amount of the debentures to be purchased plus any accrued and unpaid interest, including any additional interest to, but excluding, the repurchase date. Our common stock price exceeded the conversion threshold price of $23.36 per share for at least 20 days during the 30 consecutive trading days ended March 31, 2012. Accordingly, the 2027 Debentures are convertible at the holder’s option through June 30, 2012. If the holders were to exercise the conversion option, the principal amount is payable in cash and any amount payable in excess of the $250 million principal amount will be paid in cash or shares of our common stock, at our election. As a result, we have classified the 2027 Debentures in current liabilities as of March 31, 2012 reflecting the redemption rights of the holders to convert their debentures during the quarter ending June 30, 2012.

The difference between the carrying value of the 2027 Debentures and the $250.0 million principal amount reflects the $22.9 million unamortized portion of the original issue discount recognized upon issuance of the notes, which is being amortized over the expected term of the convertible debt. Because the 2027 Debentures were convertible at March 31, 2012, an amount equal to the $22.9 million unamortized portion of the original issue discount is separately classified in our consolidated balance sheets as temporary equity and referred to as “Equity component of currently redeemable convertible debentures.”

Credit Facility

2007 (the “Credit Facility”). In July 2011, we entered into agreements to amend and restate our existing Credit Facility. Of the approximately $638.5 million remaining term loan balance as of July 1, 2011, lenders representing $493.2 million elected to extend the maturity date by three years to March 31, 2016. The remaining $145.3 million in term loans are due March 2013. In addition, lenders participating in the revolving credit facility chose to extend the maturity date by three years to March 31, 2015. As of March 31, 2012, $633.8 million remained outstanding under the term loans, there were $15.5 million of letters of credit issued under the revolving credit line and there were no other outstanding borrowings under the revolving credit line.

The Credit Facility contains covenants, including, among other things, covenants that restrict our ability and those of our subsidiaries to incur certain additional indebtedness, create or permit liens on assets, enter into sale-leaseback transactions, make loans or investments, sell assets, make certain acquisitions, pay dividends, or repurchase stock. The agreement also contains events of default, including failure to make payments of principal or interest, failure to observe covenants, breaches of representations and warranties, defaults under certain other material indebtedness, failure to satisfy material judgments, a change of control and certain insolvency events. As of March 31, 2012, we were in compliance with the covenants under the Credit Facility.

Under terms of the amended Credit Facility, interest is payable monthly at a rate equal to the applicable margin plus, at our option, either (a) the base rate, which is the higher of the corporate base rate of UBS AG, Stamford Branch, or the federal funds rate plus 0.50% per annum, or (b) LIBOR (equal to (i) the British Bankers’ Association Interest Settlement Rates for deposits in U.S. dollars, divided by (ii) one minus the statutory reserves applicable to such borrowing). The applicable margin for the borrowings is as follows:


Description	Base Rate Margin	LIBOR Margin
Term loans maturing March 2013	0.75% - 1.50%(a)	1.75% - 2.50%(a)
Term loans maturing March 2016	2.00%	3.00%
Revolving facility due March 2015	1.25% - 2.25%(b)	2.25% - 3.25%(b)

(a)	The margin is determined based on our leverage ratio and credit rating at the date the interest rates are reset on the term loans.

(b)	The margin is determined based on our leverage ratio and credit rating at the date the interest rates are reset on the revolving credit line.

At March 31, 2012 the applicable margins were 1.75%, with an effective rate of 2.00%, on the remaining balance of $144.3 million maturing in March 2013 and 3.00%, with an effective rate of 3.25%, on the remaining balance of $489.5 million maturing in March 2016. We are required to pay a commitment fee for unutilized commitments under the revolving credit facility at a rate ranging from 0.375% to 0.50% per annum, based upon our leverage ratio. As of March 31, 2012, the commitment fee rate was 0.375%.

The amended Credit Facility includes a provision for an annual excess cash flow sweep, as defined in the agreement, payable in the first quarter of each fiscal year, based on the excess cash flow generated in the previous fiscal year. No excess cash flow sweep was required in the first quarter of fiscal 2012 as no excess cash flow, as defined, was generated in fiscal 2011. At the current time, we are unable to predict the amount of the outstanding principal, if any, that we may be required to repay in future fiscal years pursuant to the excess cash flow sweep provisions.

13.

Net Income Per Share

Common equivalent shares are excluded from the computation of diluted net income per share if their effect is anti-dilutive. Potentially dilutive common equivalent shares aggregating to 4.0 million and 3.9 million shares for the three months ended March 31, 2012 and 2011, respectively, and 3.7 million and 3.9 million shares for the six months ended March 31, 2012 and 2011, respectively, have been excluded from the computation of diluted net income per share because their inclusion would be anti-dilutive.

The following table sets forth the computation for basic and diluted net income per share in accordance with the two-class method (dollars in thousands, except per share amounts):


	Three Months Ended March 31,						Six Months Ended March 31,
	2012			2011			2012			2011
Numerator:
Basic
Net income	$	890		$	1,735		$	10,230		$	1,726
Allocation of undistributed earnings to preferred stockholders		(10	)		(20	)		(118	)		(20	)

Net income available to common stockholders — basic	$	880		$	1,715		$	10,112		$	1,706

Diluted
Net income available to common stockholders — diluted	$	890		$	1,735		$	10,230		$	1,726


	Three Months Ended March 31,				Six Months Ended March 31,
	2012		2011		2012		2011
Denominator:
Basic
Weighted average common shares outstanding		305,282		300,937		304,643		299,772

Diluted
Weighted average common shares outstanding — basic		305,282		300,937		304,643		299,772
Weighted average effect of dilutive common equivalent shares:
Assumed conversion of Series B Preferred Stock		3,562		3,562		3,562		3,562
Employee stock compensation plan		7,331		8,593		7,566		8,264
Warrants		2,702		1,514		2,745		1,367
2027 Convertible Debentures		3,614		—		3,122		—
Other contingently issuable shares		151		150		154		187

Weighted average common shares outstanding — diluted		322,642		314,756		321,792		313,152

Net income per share:
Basic	$	0.00	$	0.01	$	0.03	$	0.01

Diluted	$	0.00	$	0.01	$	0.03	$	0.01

14.

Stockholders’ Equity

Share Repurchase

On October 24, 2011, we repurchased 8,514,120 shares of our common stock for approximately $200 million using proceeds from the issuance of the 2031 Debentures. The shares were retired and are no longer available for future issuances.

Common Stock Warrants

We have, from time to time, entered into stock and warrant agreements with Warburg Pincus. In connection with these agreements, we granted Warburg Pincus the right to request that we use commercially reasonable efforts to register some or all of the shares of common stock issued to them pursuant to the purchase agreements, including shares of common stock underlying the warrants. In February 2012, Warburg Pincus elected a cashless exercise of warrants for 3,700,000 shares of common stock at $20.00 per share, resulting in a net issuance of 1,077,744 shares. At March 31, 2012, Warburg Pincus holds the following warrants to purchase shares of our common stock:

Issuance Date

Price
per
Share

Total
Shares

Expiration Date

January 29, 2009

11.57

3,862,422

January 29, 2013

15.

Stock-Based Compensation

We recognize stock-based compensation expense over the requisite service period. Our share-based awards are accounted for as equity instruments. The amounts included in the consolidated statements of operations relating to stock-based compensation are as follows (dollars in thousands):


	Three Months Ended March 31,				Six Months Ended March 31,
	2012		2011		2012		2011
Cost of product and licensing	$	10	$	21	$	102	$	27
Cost of professional services and hosting		6,105		9,062		10,511		14,750
Cost of maintenance and support		260		637		305		1,027
Research and development		5,970		8,041		11,853		12,908
Selling and marketing		10,390		12,097		22,207		22,407
General and administrative		15,286		13,761		25,830		24,598

Total	$	38,021	$	43,619	$	70,808	$	75,717

Included in stock-based compensation for the three and six months ended March 31, 2012 is $10.6 million and $17.5 million, respectively, of expense related to awards that will be made as part of the annual bonus plan to employees. The annual bonus pool is

determined by management and approved by the Compensation Committee of the Board of Directors based on financial performance targets approved at the beginning of the year. If these targets are achieved, the awards will be settled in shares based on the total bonus earned and the grant date fair value of the shares awarded to each employee.

Stock Options

The table below summarizes activity relating to stock options for the six months ended March 31, 2012:


	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value(1)
Outstanding at September 30, 2011		7,681,719		$	10.48
Exercised		(1,373,861	)	$	7.65
Forfeited		(7,665	)	$	7.97
Expired		(2,663	)	$	4.02

Outstanding at March 31, 2012		6,297,530		$	11.10		3.4 years	$	91.2 million

Exercisable at March 31, 2012		5,239,085		$	10.05		2.9 years	$	81.4 million

Exercisable at March 31, 2011		8,051,151		$	7.90		2.7 years	$	93.9 million

(1)	The aggregate intrinsic value in this table was calculated based on the positive difference, if any, between the closing market value of our common stock on March 31, 2012 ($25.58) and the exercise price of the underlying options.

As of March 31, 2012, the total unamortized fair value of stock options was $1.8 million with a weighted average remaining recognition period of 0.5 years. A summary of weighted-average grant-date fair value of stock options granted and intrinsic value of stock options exercised is as follows:


	Six Months Ended March 31,
	2012		2011
Weighted-average grant-date fair value per share		N/A	$	6.13
Total intrinsic value of stock options exercised (in millions)	$	23.7	$	15.3

Restricted Units

Restricted Units are not included in issued and outstanding common stock until the shares are vested and released. The table below summarizes activity relating to Restricted Units for the six months ended March 31, 2012:


	Number of Shares Underlying Restricted Units — Contingent Awards			Number of Shares Underlying Restricted Units — Time-Based Awards
Outstanding at September 30, 2011		2,955,179			7,286,118
Granted		2,315,500			4,856,257
Earned/released		(1,049,699	)		(2,757,831	)
Forfeited		(280,713	)		(277,621	)

Outstanding at March 31, 2012		3,940,267			9,106,923

Weighted average remaining contractual term of outstanding Restricted Units		1.5 years			1.3 years
Aggregate intrinsic value of outstanding Restricted Units(1)	$	100.8 million		$	233.1 million
Restricted Units vested and expected to vest		3,688,886			8,084,801
Weighted average remaining contractual term of Restricted Units vested and expected to vest		1.4 years			1.3 years
Aggregate intrinsic value of Restricted Units vested and expected to vest(1)	$	94.4 million		$	206.8 million

(1)	The aggregate intrinsic value in this table was calculated based on the positive difference between the closing market value of our common stock on March 31, 2012 ($25.58) and the exercise price of the underlying Restricted Units.

The purchase price for vested Restricted Units is $0.001 per share. As of March 31, 2012, unearned stock-based compensation expense related to all unvested Restricted Units is $238.4 million, which will, based on expectations of future performance vesting criteria, where applicable, be recognized over a weighted-average period of 1.3 years.

A summary of weighted-average grant-date fair value, including those assumed in respective periods, and intrinsic value of all Restricted Units vested is as follows:


	Six Months Ended March31,
	2012		2011
Weighted-average grant-date fair value per share	$	25.76	$	17.34
Total intrinsic value of shares vested (in millions)	$	93.8	$	67.7

Restricted Stock Awards

Restricted Stock Awards are included in the issued and outstanding common stock at the date of grant. During the six months ended March 31, 2012, we granted 750,000 Restricted Stock Awards with a weighted average grant date fair value of $25.80. As of March 31, 2012, unearned share-based payment expense related to unvested Restricted Stock Awards is $16.9 million, which will be recognized over a weighted-average remaining period of 2.6 years.

16.

Income Taxes

The effective income tax rate was 92.7% and 17.1% for the three and six months ended March 31, 2012 respectively, and was 58.5% and 83.2% for the three and six months ended March 31, 2011, respectively. The change in the effective tax rate and income tax provision for the three month period primarily relates to an increase in domestic and international profits in the three month period ended March 31, 2012. The domestic provision increased by $5.9 million and the international increased by $0.7 million. The six month period reflects a decrease to the tax provision of $6.3 million. This is driven by the increase in domestic and international profits, offset by a one-time tax benefit recorded of $12.2 million in the period ended March 31, 2012 in connection with the acquisition of Swype.

At March 31, 2012 and September 30, 2011, the liability for income taxes associated with uncertain tax positions was $15.4 million and $14.9 million, respectively. We do not expect a significant change in the amount of unrecognized tax benefits within the next 12 months.

17.

Commitments and Contingencies

Litigation and Other Claims

Like many companies in the software industry, we have, from time to time, been notified of claims that we may be infringing, or contributing to the infringement of, the intellectual property rights of others. These claims have been referred to counsel, and they are in various stages of evaluation and negotiation. If it appears necessary or desirable, we may seek licenses for these intellectual property rights. There is no assurance that licenses will be offered by all claimants, that the terms of any offered licenses will be acceptable to us or that in all cases the dispute will be resolved without litigation, which may be time consuming and expensive, and may result in injunctive relief or the payment of damages by us.

We do not believe that the final outcome of the above referenced litigation matters will have a material adverse effect on our financial position and results of operations. However, even if our defense is successful, the litigation could require significant management time and will be costly. Should we not prevail, our operating results, financial position and cash flows could be adversely impacted.

Guarantees and Other

We include indemnification provisions in the contracts we enter into with customers and business partners. Generally, these provisions require us to defend claims arising out of our products’ infringement of third-party intellectual property rights, breach of contractual obligations and/or unlawful or otherwise culpable conduct. The indemnity obligations generally cover damages, costs and attorneys’ fees arising out of such claims. In most, but not all cases, our total liability under such provisions is limited to either the value of the contract or a specified, agreed upon amount. In some cases our total liability under such provisions is unlimited. In many, but not all cases, the term of the indemnity provision is perpetual. While the maximum potential amount of future payments we could be required to make under all the indemnification provisions is unlimited, we believe the estimated fair value of these provisions is minimal due to the low frequency with which these provisions have been triggered.

We indemnify our directors and officers to the fullest extent permitted by law. These agreements, among other things, indemnify directors and officers for expenses, judgments, fines, penalties and settlement amounts incurred by such persons in their capacity as a director or officer of the company, regardless of whether the individual is serving in any such capacity at the time the liability or expense is incurred. Additionally, in connection with certain acquisitions we have agreed to indemnify the former officers and members of the boards of directors of those companies, on similar terms as described above, for a period of six years from the acquisition date. In certain cases we purchase director and officer insurance policies related to these obligations, which fully cover the six year periods. To the extent that we do not purchase a director and officer insurance policy for the full period of any contractual indemnification, we would be required to pay for costs incurred, if any, as described above.

18.

Segment and Geographic Information and Significant Customers

We operate in, and report financial information for, the following four reportable segments: Healthcare, Mobile and Consumer, Enterprise and Imaging. Segment profit is an important measure used for evaluating performance and for decision-making purposes. Segment profit represents income from operations excluding stock-based compensation, amortization of intangible assets, acquisition-related costs, net, restructuring and other charges, net, costs associated with intellectual property collaboration agreements, other income (expense), net and certain unallocated corporate expenses. Segment profit includes an adjustment for acquisition-related revenue and cost of revenue which includes revenue from acquisitions that would have otherwise been recognized but for the purchase accounting treatment of these transactions. We believe that these revenue and cost of revenue adjustments allow for more complete comparisons to the financial results of the historical operations.

We do not track our assets by operating segment, consequently, it is not practical to show assets or depreciation by operating segment. The following table presents segment results along with a reconciliation of segment profit to Income before income taxes (dollars in thousands):


	Three Months Ended March 31,						Six Months Ended March 31,
	2012			2011			2012			2011
Segment revenues(a):
Healthcare	$	149,940		$	121,032		$	295,190		$	238,838
Mobile and Consumer		115,064			93,742			223,584			181,483
Enterprise		91,368			73,989			167,211			146,438
Imaging		61,349			43,247			113,785			82,513

Total segment revenues		417,721			332,010			799,770			649,272
Acquisition related revenue		(27,380	)		(13,048	)		(48,786	)		(26,481	)

Total consolidated revenue		390,341			318,962			750,984			622,791

Segment profit(b):
Healthcare		69,669			57,763			143,725			114,636
Mobile and Consumer		49,727			41,477			84,568			70,002
Enterprise		32,648			14,764			47,725			31,091
Imaging		27,954			18,974			48,824			34,816

Total segment profit		179,998			132,978			324,842			250,545

Corporate expenses and other, net		(26,436	)		(23,883	)		(47,218	)		(44,630	)
Acquisition-related revenues and costs of revenue adjustment		(25,250	)		(10,496	)		(44,336	)		(21,302	)
Stock-based compensation		(38,021	)		(43,619	)		(70,808	)		(75,717	)
Amortization of intangible assets		(36,772	)		(35,735	)		(74,909	)		(71,703	)
Acquisition-related costs, net		(14,986	)		(2,314	)		(29,597	)		(5,315	)
Restructuring and other charges, net		(2,536	)		(2,428	)		(5,400	)		(4,479	)
Costs associated with IP collaboration agreements		(5,250	)		(4,625	)		(10,500	)		(9,250	)
Other income (expense), net		(18,390	)		(5,756	)		(29,786	)		(8,015	)

Income before income taxes	$	12,357		$	4,122		$	12,288		$	10,134

(a)

Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that would otherwise have been recognized but for the purchase accounting treatment of the business combinations. Segment revenues also include revenue that the business would have otherwise recognized had we not acquired intellectual property and other assets from the same customer. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance.

(b)	Segment profit reflects the direct controllable costs of each segment together with an allocation of sales and corporate marketing expenses, and certain research and development project costs that benefit multiple product offerings.

No country outside of the United States provided greater than 10% of our total revenue. Revenue, classified by the major geographic areas in which our customers are located, was as follows (dollars in thousands):


	Three Months Ended March 31,				Six Months Ended March 31,
	2012		2011		2012		2011
United States	$	259,162	$	232,261	$	535,624	$	463,951
International		131,179		86,701		215,360		158,840

Total Revenue	$	390,341	$	318,962	$	750,984	$	622,791

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis is intended to help the reader understand the results of operations and financial condition of our business. Management’s Discussion and Analysis is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes to the consolidated financial statements.

CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q including the sections entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Quantitative and Qualitative Disclosure About Market Risk” under Items 2 and 3, respectively, of Part I of this report, and the sections entitled “Legal Proceedings,” “Risk Factors,” and “Unregistered Sales of Equity Securities and Use of Proceeds” under Items 1, 1A and 2, respectively, of Part II of this report, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that, if they never materialize or if they prove incorrect, could cause our consolidated results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements include predictions regarding:

•

our future revenues, cost of revenues, research and development expenses, selling, general and administrative expenses, amortization of intangible assets and gross margin;

•

our strategy relating to our segments;

•

the potential of future product releases;

•

our product development plans and investments in research and development;

•

future acquisitions, and anticipated benefits from acquisitions;

•

international operations and localized versions of our products; and

•

legal proceedings and litigation matters.

You can identify these and other forward-looking statements by the use of words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “intends,” “potential,” “continue” or the negative of such terms, or other comparable terminology. Forward-looking statements also include the assumptions underlying or relating to any of the foregoing statements. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks described in Item 1A — “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q.

You should not place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report on Form 10-Q. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We undertake no obligation to publicly release any revisions to the forward-looking statements or reflect events or circumstances after the date of this document.

OVERVIEW

Business Overview

Nuance Communications, Inc. is a leading provider of voice and language solutions for businesses and consumers around the world. Our technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Our solutions are used every day by millions of people and thousands of businesses for tasks and services such as requesting information from a phone-based self-service solution, dictating medical records, searching the mobile Web by voice, entering a destination into a navigation system, or working with PDF documents. Our solutions help make these interactions, tasks and experiences more productive, compelling and efficient.

We are organized in four segments; Healthcare, Mobile and Consumer, Enterprise, and Imaging. Our solutions and services address our four segments:

•

Healthcare. We provide comprehensive dictation and transcription solutions and services that automate the input and management of medical information. Our hosted and on-premise solutions provide platforms to generate and distribute clinical documentation through the use of advanced dictation and transcription features, supplemented with editing services, and allow us to deliver scalable, highly productive medical transcription solutions. Our solutions also enable us to accelerate future innovation to transform the way healthcare providers document patient care, through improved interface with electronic medical records and extraction of clinical information to support the billing and insurance reimbursement processes. We also offer speech recognition solutions for radiology, cardiology, pathology and related specialties, that help healthcare providers dictate, edit and sign reports without manual transcription. Trends in our healthcare business include a growing customer preference for on-demand solutions, an increasing proportion of our subscription services also including editing, implementation of electronic healthcare records which we service through license offerings, increasing interest in the use of mobile devices to access healthcare systems and records, and increasing international interest. Over the last several quarters, we have signed several new contracts for our hosted solutions as well as several new contracts to add editing services into existing hosting contracts, resulting in increased average revenue per line, and the volume of lines processed in these services has steadily increased. We are investing to expand our product set to address these opportunities, expand our international capabilities, and reduce our time from contract signing to initiation of billable services.

•

Mobile and Consumer. Our portfolio of mobile and consumer solutions and services includes an integrated suite of voice control and text-to-speech solutions, dictation applications, predictive text technologies, mobile messaging services and emerging services such as dictation, Web search, virtual assistant and voicemail-to-text. Our suite of Dragon general purpose desktop and portable computer dictation applications increases productivity by using speech to create documents, streamline repetitive and complex tasks, input data, complete forms and automate manual transcription processes. In particular, we have focused in recent quarters on integrating our Dragon technology and brand initiatives across mobile and consumer markets. Trends in our mobile and consumer segment include device manufacturers requiring custom applications to deliver unique and differentiated products, broadening keyboard technologies to take advantage of touch screens, increasing hands-free capabilities on cell phones and automobiles to address the growing concern of distracted driving, and the adoption of our technology on a broadening scope of devices, such as televisions, set-top boxes, e-book readers and tablet computers. We are investing to increase our capabilities and capacity to help device manufacturers build custom applications, to increase the capacity of our data centers, to increase the number, kinds and capacity of network services, to enable developers to access our technology, and to expand both awareness and channels for our direct-to-consumer products.

•

Enterprise. We deliver a portfolio of customer service business intelligence and authentication solutions that are designed to help companies better support, understand and communicate with their customers. Our solutions include the use of technologies such as speech recognition, natural language understanding, text-to-speech, biometric voice recognition and analytics to automate caller identification and authorization, call steering, completion of tasks such as updates, purchases and information retrieval, and automated outbound notifications. Our solutions improve the customer experience, increase the use of self-service and enable new revenue opportunities. In addition, we offer solutions that can meet customer care needs through direct interaction with thin-client applications on cell phones, enabling customers to very quickly retrieve relevant information. Trends in our enterprise business include increasing interest in the use of mobile applications to access customer care systems and records, increasing interest in coordinating actions and data across customer care channels, and the ability of a broader set of hardware providers and systems integrators to serve the market. We are investing to expand our product set to address these opportunities, to increase efficiency of our hosted applications, expand our capabilities and capacity to help customers build custom applications, and broaden our relationships with new hardware and systems integrator partners serving the market.

•

Imaging. Our imaging solutions offer optical character recognition technology to deliver highly accurate document scanning and storage. We provide networked print management and comprehensive PDF applications designed specifically for business users. In addition, we offer applications that combine network scanning, network print management and PDF creation to quickly enable distribution of documents to users’ desktops or to enterprise applications. Our host of services includes software development toolkits for independent software vendors. The imaging market is evolving to include more

networked solutions, mobile access to networked solutions, and multi-function devices. We are investing to improve mobile access to our networked products, expand our distribution channels and embedding relationships, and expand our language coverage.

We leverage our global professional services organization and our extensive network of partners to design and deploy innovative solutions for businesses and organizations around the globe. We market and sell our products directly through a dedicated sales force, through our e-commerce website, and also through a global network of resellers, including system integrators, independent software vendors, value-added resellers, hardware vendors, telecommunications carriers and distributors.

We have built a world-class portfolio of intellectual property, technologies, applications and solutions through both internal development and acquisitions. We expect to continue to pursue opportunities to broaden these assets and expand our customer base through acquisitions.

Confronted by dramatic increases in electronic information, consumers, business personnel and healthcare professionals must use a variety of resources to retrieve information, transcribe patient records, conduct transactions and perform other job-related functions. We believe that the power of our solutions can transform the way people use the Internet, telecommunications systems, electronic medical records, wireless and mobile networks and related corporate infrastructure to conduct business.

Strategy

In fiscal 2012, we will continue to focus on growth by providing market-leading, value-added solutions for our customers and partners through a broad set of technologies, service offerings and channel capabilities. We will also continue to focus on operating efficiencies, expense discipline and acquisition synergies to improve gross margins and operating margins. We intend to pursue growth through the following key elements of our strategy:

•

Extend Technology Leadership. Our solutions are recognized as among the best in their respective categories. We intend to leverage our global research and development organization and broad portfolio of technologies, applications and intellectual property to foster technological innovation and maintain customer preference for our solutions. We also intend to invest in our engineering resources and seek new technological advancements that further expand the addressable markets for our solutions.

•

Broaden Expertise in Vertical Markets. Businesses are increasingly turning to Nuance for comprehensive solutions rather than for a single technology product. We intend to broaden our expertise and capabilities to deliver targeted solutions for a range of industries including mobile device manufacturers, healthcare, telecommunications, financial services and government administration. We also intend to expand our global sales and professional services capabilities to help our customers and partners design, integrate and deploy innovative solutions.

•

Increase Subscription and Transaction Based Recurring Revenue. We intend to increase our subscription and transaction based offerings in our segments. The expansion of our subscription or transaction based solutions will enable us to deliver applications that our customers use on a repeat basis, and pay for on a per use basis, providing us with the opportunity to enjoy the benefits of recurring revenue streams.

•

Expand Global Presence. We intend to further expand our international resources to better serve our global customers and partners and to leverage opportunities in emerging markets such as Asia and Latin America. We continue to add regional executives and sales employees in different geographic regions to better address demand for voice and language based solutions and services.

•

Pursue Strategic Acquisitions and Partnerships. We have selectively pursued strategic acquisitions to expand our technology, solutions and resources to complement our organic growth. We have also formed key partnerships with other important companies in our markets of interest, and intend to continue to do so in the future where it will enhance the value of our business. We have proven experience in integrating businesses and technologies and in delivering enhanced value to our customers, partners, employees and shareholders. We intend to continue to pursue acquisitions that enhance our solutions, serve specific vertical markets and strengthen our technology portfolio.

Key Metrics

In evaluating the financial condition and operating performance of our business, management focuses on revenue, net income, gross margins, operating margins and cash flow from operations. A summary of these key financial metrics for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, is as follows:

•

Total revenue increased by $128.2 million to $751.0 million;

•

Net income improved to $10.2 million from $1.7 million in fiscal 2011;

•

Gross margins increased by 2.2 percentage points to 63.3%;

•

Operating margins increased by 2.7 percentage point to 5.6%; and

•

Cash provided by operating activities increased by $30.7 million to $190.1 million.

In addition to the above key financial metrics, we also focus on certain non-financial performance indicators. A summary of these key non-financial performance indicators as of and for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, is as follows:

•

Annualized line run-rate in our on-demand healthcare solutions increased 13% to approximately 4.1 billion lines per year. The annualized line run-rate is determined using billed equivalent line counts in a given quarter, multiplied by four;

•

Estimated three-year value of on-demand contracts increased 13% to approximately $1.4 billion. We determine this value as of the end of the period reported, by using our best estimate of all anticipated future revenue streams under signed on-demand contracts then in place, whether or not they are guaranteed through a minimum commitment clause. Our best estimate is based on estimates used in evaluating the contracts and determining sales compensation, adjusted for changes in estimated launch dates, actual volumes achieved and other factors deemed relevant. For contracts with an expiration date beyond three years, we include only the value expected within three years. For other contracts, we assume renewal consistent with historic renewal rates unless there is a known cancellation. Contracts are generally priced by volume of usage and typically have no or low minimum commitments. Actual revenue could vary from our estimates due to factors such as cancellations, non-renewals or volume fluctuations.

RESULTS OF OPERATIONS

Total Revenues

The following tables show total revenues by product type and by geographic location, based on the location of our customers, in dollars and percentage change (dollars in millions):


	Three Months Ended March 31,				Dollar		Percent			Six Months Ended March 31,				Dollar		Percent
	2012		2011		Change		Change			2012		2011		Change		Change
Product and licensing	$	176.5	$	141.6	$	34.9		24.6	%	$	341.2	$	275.5	$	65.7		23.8	%
Professional services and hosting		155.5		128.9		26.6		20.6	%		295.1		251.7		43.4		17.2	%
Maintenance and support		58.3		48.5		9.8		20.2	%		114.7		95.6		19.1		20.0	%

Total Revenues	$	390.3	$	319.0	$	71.3		22.4	%	$	751.0	$	622.8	$	128.2		20.6	%

United States	$	259.1	$	232.3	$	26.8		11.5	%	$	535.6	$	464.0	$	71.6		15.4	%
International		131.2		86.7		44.5		51.3	%		215.4		158.8		56.6		35.6	%

Total Revenues	$	390.3	$	319.0	$	71.3		22.4	%	$	751.0	$	622.8	$	128.2		20.6	%

The geographic split for the six months ended March 31, 2012, was 71% of total revenues in the United States and 29% internationally, compared to 75% of total revenues in the United States and 25% internationally for the same period last year. The increase in the proportion of revenue generated internationally resulted from growth in the Mobile and Consumer and Imaging segments.

Product and Licensing Revenue

Product and licensing revenue primarily consists of sales and licenses of our technology. The following table shows product and licensing revenue, in dollars and as a percentage of total revenues (dollars in millions):


	Three Months Ended March 31,						Dollar		Percent			Six Months Ended March 31,						Dollar		Percent
	2012			2011			Change		Change			2012			2011			Change		Change
Product and licensing revenue	$	176.5		$	141.6		$	34.9		24.6	%	$	341.2		$	275.5		$	65.7		23.8	%

As a percentage of total revenue		45.2	%		44.4	%							45.4	%		44.2	%

The increase in product and licensing revenue for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, consisted of a $13.4 million increase in Imaging product and licensing revenue primarily driven by sales of our multi-functional peripheral (“MFP”) products, which included revenues associated with our acquisition of Equitrac in the third quarter of fiscal 2011. Mobile and Consumer revenue increased $12.4 million driven by a $13.8 million increase in sales of our embedded solutions. Healthcare product and licensing revenue increased $5.6 million resulting from continued strength in sales of our Dragon Medical solutions primarily to service electronic healthcare records.

The increase in product and licensing revenue for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, consisted of a $25.5 million increase in Mobile and Consumer revenue driven by a $19.9 million increase in sales of

our embedded solutions. Imaging product and licensing revenues increased $19.7 million, primarily driven by sales of our MFP products, which included revenues associated with our acquisition of Equitrac in the third quarter of fiscal 2011. Healthcare product and licensing revenues increase $17.0 million resulting from continued strength in sales of our Dragon Medical solutions primarily to service electronic healthcare records.

Professional Services and Hosting Revenue

Professional services revenue primarily consists of consulting, implementation and training services for speech customers. Hosting revenue primarily relates to delivering hosted services, such as medical transcription, automated customer care applications, voice message transcription, and mobile search and transcription, over a specified term. The following table shows professional services and hosting revenue, in dollars and as a percentage of total revenues (dollars in millions):


	Three Months Ended March 31,						Dollar		Percent			Six Months Ended March 31,						Dollar		Percent
	2012			2011			Change		Change			2012			2011			Change		Change
Professional services and hosting revenue	$	155.5		$	128.9		$	26.6		20.6	%	$	295.1		$	251.7		$	43.4		17.2	%

As a percentage of total revenue		39.8	%		40.4	%							39.3	%		40.4	%

The increase in professional services and hosting revenue for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, consisted of a $20.9 million increase in Healthcare revenue primarily driven by transactional volume growth in our on-demand solutions, of which $8.5 million was due to our acquisition of Webmedx during fiscal 2011. Mobile and Consumer professional services and hosting revenue increased $5.9 million, primarily attributable to an increase in connected mobile services in the quarter.

The increase in professional services and hosting revenue for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, consisted of a $35.1 million increase in Healthcare revenue primarily driven by transactional volume growth in our on-demand solutions, of which $16.7 million was due to our acquisition of Webmedx during fiscal 2011. Mobile and Consumer revenue increased $10.1 million primarily as a result of growth in our connected mobile services.

Maintenance and Support Revenue

Maintenance and support revenue primarily consists of technical support and maintenance services. The following table shows maintenance and support revenue, in dollars and as a percentage of total revenues (dollars in millions):


	Three Months Ended March 31,						Dollar		Percent			Six Months Ended March 31,						Dollar		Percent
	2012			2011			Change		Change			2012			2011			Change		Change
Maintenance and Support revenue	$	58.3		$	48.5		$	9.8		20.2	%	$	114.7		$	95.6		$	19.1		20.0	%

As a percentage of total revenue		15.0	%		15.2	%							15.3	%		15.4	%

The increase in maintenance and support revenue for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, was driven by the related growth in our product and licensing sales. The change included a $4.5 million increase in Imaging revenue mainly due to our acquisition of Equitrac, and a $4.0 million increase in Enterprise revenue.

The increase in maintenance and support revenue for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, was consistent with the related growth in product and licensing revenue. The change included an $8.9 million increase in Imaging revenue mainly due to our acquisition of Equitrac, a $6.6 million increase in Enterprise revenue and a $4.6 million increase in Healthcare revenue driven by growth in product and licensing sales of our Dragon Medical solutions.

Costs and Expenses

Cost of Product and Licensing Revenue

Cost of product and licensing revenue primarily consists of material and fulfillment costs, manufacturing and operations costs and third-party royalty expenses. The following table shows cost of product and licensing revenue, in dollars and as a percentage of product and licensing revenue (dollars in millions):


	Three Months Ended March 31,						Dollar		Percent			Six Months Ended March 31,						Dollar		Percent
	2012			2011			Change		Change			2012			2011			Change		Change
Cost of product and licensing revenue	$	17.7		$	15.0		$	2.7		18.0	%	$	36.5		$	32.1			4.4		13.7	%

As a percentage of product and licensing revenue		10.0	%		10.6	%							10.7	%		11.7	%

The increase in cost of product and licensing revenue for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, was primarily due to a $1.6 million increase in Imaging costs driven by our acquisition of Equitrac. Gross margin increased 0.6 percentage points primarily driven by increased margins in our Enterprise on-premise related to lower cost from third party licensing, increased margins in Imaging core licenses due to lower cost of sales, offset by a reduction in margins relating to increased product costs in our Dragon Medical business.

The increase in cost of product and licensing revenue for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, was primarily due to a $2.8 million increase in Imaging costs driven by our acquisition of Equitrac. Gross margin increased 1.0 percentage points primarily driven by increased margins in our Enterprise on-premise license business due to lower costs from third party licensing and an increase in Imaging margins licenses due to lower product costs, offset by a reduction in margins relating to increased product costs in our Dragon Medical business.

Cost of Professional Services and Hosting Revenue

Cost of professional services and hosting revenue primarily consists of compensation for consulting personnel, outside consultants and overhead, as well as the hardware and communications fees that support our hosting solutions. The following table shows cost of professional services and hosting revenue, in dollars and as a percentage of professional services and hosting revenue (dollars in millions):


	Three Months Ended March 31,						Dollar		Percent			Six Months Ended March 31,						Dollar		Percent
	2012			2011			Change		Change			2012			2011			Change		Change
Cost of professional services and hosting revenue	$	97.2		$	86.5		$	10.7		12.4	%	$	187.4		$	164.7		$	22.7		13.8	%

As a percentage of professional services and hosting revenue		62.5	%		67.1	%							63.5	%		65.4	%

The increase in cost of professional services and hosting revenue for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, was primarily due to a $12.9 million increase in Healthcare costs related to growth in our on-demand solutions, including the impact from our acquisition of Webmedx. Gross margin increased 4.6 percentage points primarily due to a $3.0 million reduction in stock based compensation and a reduction in costs due to an increase in automation services relating to our connected mobile services.

The increase in cost of professional services and hosting revenue for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011 was primarily due to a $22.1 million increase in Healthcare costs related to growth in our on-demand solutions, including the impact from our acquisition of Webmedx. Gross margin increased 1.9 percentage points primarily due to a $4.2 million reduction in stock based compensation and a reduction in costs due to an increase in automation services relating to our connected mobile services.

Cost of Maintenance and Support Revenue

Cost of maintenance and support revenue primarily consists of compensation for product support personnel and overhead. The following table shows cost of maintenance and support revenue, in dollars and as a percentage of maintenance and support revenue (dollars in millions):


	Three Months Ended March 31,						Dollar		Percent			Six Months Ended March 31,						Dollar		Percent
	2012			2011			Change		Change			2012			2011			Change		Change
Cost of maintenance and support revenue	$	10.9		$	9.5		$	1.4		14.7	%	$	21.9		$	17.8		$	4.1		23.0	%

As a percentage of maintenance and support revenue		18.7	%		19.6	%							19.1	%		18.6	%

The increase in cost of maintenance and support revenue for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, was primarily due to the costs related to the increased revenue from our Imaging MFP products, which included the impact from the acquisition of Equitrac during fiscal 2011. Gross margin remained relatively flat.

The increase in cost of maintenance and support revenue for the six months ended March 31, 2012, as compared to the same periods in 2011, was primarily due to $3.5 million increase in Imaging costs related to increase revenue from our MFP products, which included the impact from the acquisition of Equitrac during fiscal 2011. Gross margin remained relatively flat.

Research and Development Expense

Research and development expense primarily consists of salaries, benefits, overhead relating to engineering staff as well as third party engineering costs. The following table shows research and development expense, in dollars and as a percentage of total revenues (dollars in millions):


	Three Months Ended March 31,						Dollar Change		Percent Change			Six Months Ended March 31,						Dollar Change		Percent Change
	2012			2011			Dollar Change		Percent Change			2012			2011			Dollar Change		Percent Change
Total research and development expense	$	54.0		$	46.3		$	7.7		16.6	%	$	106.0		$	87.7		$	18.3		20.9	%

As a percentage of total revenue		13.8	%		14.5	%							14.1	%		14.1	%

The increase in research and development expense for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, was primarily attributable to a $4.9 million increase in compensation expense. The increase in compensation expense was due to headcount growth as we continue to invest in our research and development organization, including additional headcount from our acquisitions during the second half of fiscal 2011.

The increase in research and development expense for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, was attributable to a $13.0 million increase in compensation expense driven by headcount growth as we continue to invest in our research and development organization.

Sales and Marketing Expense

Sales and marketing expense includes salaries and benefits, commissions, advertising, direct mail, public relations, tradeshow costs and other costs of marketing programs, travel expenses associated with our sales organization and overhead. The following table shows sales and marketing expense, in dollars and as a percentage of total revenues (dollars in millions):


	Three Months Ended March 31,						Dollar Change		Percent Change			Six Months Ended March 31,						Dollar Change		Percent Change
	2012			2011			Dollar Change		Percent Change			2012			2011			Dollar Change		Percent Change
Total sales and marketing expense	$	84.4		$	74.1		$	10.3		13.9	%	$	174.8		$	152.5		$	22.3		14.6	%

As a percentage of total revenue		21.6	%		23.2	%							23.3	%		24.5	%

The increase in sales and marketing expense for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, was attributable to a $7.7 million increase in compensation and employee-related costs, driven primarily by additional headcount from our acquisitions during the second half of fiscal 2011.

The increase in sales and marketing expense for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, was primarily attributable to a $9.7 million increase in marketing and channel program spending to drive revenue growth as part of demand generation activities during the holiday season, as well as an $12.6 million increase in compensation and employee-related costs.

General and Administrative Expense

General and administrative expense primarily consists of personnel costs for administration, finance, human resources, information systems, facilities and general management; fees for external professional advisors including accountants and attorneys, insurance; and provisions for doubtful accounts. The following table shows general and administrative expense, in dollars and as a percentage of total revenues (dollars in millions):


	Three Months Ended March 31,						Dollar Change		Percent Change			Six Months Ended March 31,						Dollar Change		Percent Change
	2012			2011			Dollar Change		Percent Change			2012			2011			Dollar Change		Percent Change
Total general and administrative expense	$	41.1		$	37.2		$	3.9		10.5	%	$	72.5		$	68.4		$	4.1		6.0	%

As a percentage of total revenue		10.5	%		11.7	%							9.7	%		11.0	%

The increase in general and administrative expense for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, was primarily attributable to a $4.1 million increase in compensation expense driven by additional headcount due to operational growth.

The increase in general and administrative expense for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, was primarily attributable to a $6.5 million increase in compensation expense driven by additional headcount due to operational growth, offset by a $2.4 million decrease in legal costs primarily associated with on-going litigation.

Amortization of Intangible Assets

Amortization of acquired patents and core and completed technology are included in cost of revenue and the amortization of acquired customer and contractual relationships, non-compete agreements, acquired trade names and trademarks, and other intangibles are included in operating expenses. Customer relationships are amortized on an accelerated basis based upon the pattern in which the economic benefits of the customer relationships are being realized. Other identifiable intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense was recorded as follows (dollars in millions):


	Three Months Ended March 31,						Dollar Change		Percent Change			Six Months Ended March 31,						Dollar Change		Percent Change
	2012			2011			Dollar Change		Percent Change			2012			2011			Dollar Change		Percent Change
Cost of revenue	$	14.9		$	14.2		$	0.7		4.9	%	$	29.8		$	27.5		$	2.3		8.4	%
Operating expenses		21.9			21.6			0.3		1.4	%		45.1			44.2			0.9		2.0	%

Total amortization expense	$	36.8		$	35.8		$	1.0		2.8	%	$	74.9		$	71.7		$	3.2		4.5	%

As a percentage of total revenue		9.4	%		11.2	%							10.0	%		11.5	%

The increase in amortization of intangible assets for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, was primarily attributable to the amortization of acquired intangible assets from our business and technology acquisitions during the second half of fiscal 2011 and in fiscal 2012.

The increase in amortization of intangible assets for the six months ended March 31, 2012, as compared to the same periods in 2011, was primarily attributable to the amortization of acquired intangible assets from our business acquisitions during fiscal 2011 and our acquisitions of patents and technology from other third-parties during fiscal 2011. This increase was partially offset by a reduction in amortization of customer relationships that are recognized over the period of expected economic benefit.

Acquisition-Related Costs, Net


	Three Months Ended March 31,						Dollar Change			Percent Change			Six Months Ended March 31,						Dollar Change			Percent Change
	2012			2011			Dollar Change			Percent Change			2012			2011			Dollar Change			Percent Change
Transition and integration costs	$	2.9		$	0.1		$	2.8			2,800.0	%	$	6.2		$	1.1		$	5.1			463.6	%
Professional service fees		12.2			2.0			10.2			510.0	%		22.7			3.3			19.4			587.9	%
Acquisition-related adjustments		(0.1	)		0.2			(0.3	)		(150.0	)%		0.7			0.9			(0.2	)		(22.2	)%

Total Acquisition-related costs, net	$	15.0		$	2.3		$	12.7			552.2	%	$	29.6		$	5.3		$	24.3			458.5	%

As a percentage of total revenue		3.8	%		0.7	%								3.9	%		0.9	%

Restructuring and Other Charges, Net

The following table sets forth the activity relating to the restructuring accruals included in Restructuring and other charges, net for the six months ended March 31, 2012 (dollars in millions):


	Personnel			Facilities			Total
Balance at September 30, 2011	$	5.1		$	1.0		$	6.1
Restructuring and other charges		4.7			0.6			5.3
Cash payments		(6.3	)		(1.0	)		(7.3	)

Balance at March 31, 2012	$	3.5		$	0.6		$	4.1

Other Income (Expense)

Other income (expense) consists of interest income, interest expense, gain (loss) from security price guarantee derivatives, gain (loss) from foreign exchange, and gains (losses) from other non-operating activities. The following table shows other income (expense), in dollars and as a percentage of total revenues (dollars in millions):


	Three Months Ended March 31,						Dollar Change			Percent Change			Six Months Ended March 31,						Dollar Change			Percent Change
	2012			2011			Dollar Change			Percent Change			2012			2011			Dollar Change			Percent Change
Interest income	$	0.6		$	0.7		$	(0.1	)		(14.3	)%	$	1.2		$	1.5		$	(0.3	)		(20.0	)%
Interest expense		(20.0	)		(8.8	)		(11.2	)		(127.3	)%		(37.7	)		(18.1	)		(19.6	)		(108.3	)%
Other income (expense), net		0.9			2.4			(1.5	)		(62.5	)%		6.6			8.6			(2.0	)		(23.3	)%

Total other income (expense), net	$	(18.5	)	$	(5.7	)	$	(12.8	)		(224.6	)%	$	(29.9	)	$	(8.0	)	$	(21.9	)		(273.8	)%

As a percentage of total revenue		(4.7	)%		(1.8	)%								(4.0	)%		(1.3	)%

The increase in interest expense for the three and six months ended March 31, 2012, as compared to the three and six months ended March 31, 2011, was due to the issuance of the 2031 Debentures in the first quarter of fiscal 2012. This increased cash interest expense by $4.7 million and $8.3 million and non-cash interest by $5.6 million and $9.5 million for the three and six month periods, respectively.

Provision for Income Taxes

The following table shows the provision for income taxes and the effective income tax rate (dollars in millions):


	Three Months Ended March 31,						Dollar Change		Percent Change			Six Months Ended March 31,						Dollar Change			Percent Change
	2012			2011			Dollar Change		Percent Change			2012			2011			Dollar Change			Percent Change
Income before income taxes	$	12.4		$	4.1		$	8.3		202.4	%	$	12.3		$	10.1		$	2.2			21.8	%
Income tax provision	$	11.5		$	2.4		$	9.1		379.2	%	$	2.1		$	8.4		$	(6.3	)		(75.0	)%

Effective income tax rate		92.7	%		58.5	%				34.2	%		17.1	%		83.2	%					(66.1	)%

SEGMENT ANALYSIS

We operate in, and report financial information for, the following four reportable segments: Healthcare, Mobile and Consumer, Enterprise and Imaging. The Healthcare segment is primarily engaged in voice and language recognition for healthcare information management offered both by licensing and on-demand services. The Mobile and Consumer segment is primarily engaged in sales of voice and language solutions that are embedded in a device (such as a cell phone, car or tablet computer) or installed on a personal computer. Our Enterprise segment offers voice and language solutions by licensing as well as on-demand solutions hosted by us that are designed to help companies better support, understand and communicate with their customers. The Imaging segment sells document capture and print management solutions that are embedded in copiers and multi-function printers as well as packaged software for document management.

Segment revenues include revenue related to acquisitions, primarily from the fiscal 2010 eCopy transaction and the fiscal 2011 purchases of Equitrac and Loquendo that would otherwise have been recognized but for the purchase accounting treatment of these transactions. Segment revenues also include revenue that we would have otherwise recognized had we not acquired intellectual property and other assets from the same customer during the same quarter. We include these revenues and the related cost of revenues to allow for more complete comparisons to the financial results of historical operations, forward-looking guidance and the financial results of peer companies and in assessing management performance.

Segment profit is an important measure used for evaluating performance and for decision-making purposes. Segment profit reflects the direct controllable costs of each segment together with an allocation of sales and corporate marketing expenses, and certain research and development project costs that benefit multiple product offerings. Segment profit represents income from operations excluding stock-based compensation, amortization of intangible assets, acquisition-related costs, net, restructuring and other charges, net, costs associated with intellectual property collaboration agreements, other income (expense), net and certain unallocated corporate expenses. Segment profit includes an adjustment for acquisition-related revenues and cost of revenues which includes revenue from acquisitions that would have otherwise been recognized but for the purchase accounting treatment of these transactions. We believe that these adjustments allow for more complete comparisons to the financial results of the historical operations. The following table presents segment results (dollars in millions):


	Three Months Ended March 31,						Change			Percent Change			Six Months Ended March 31,						Change			Percent Change
	2012			2011			Change			Percent Change			2012			2011			Change			Percent Change
Segment Revenues
Healthcare	$	149.9		$	121.0		$	28.9			23.9	%	$	295.2		$	238.8		$	56.4			23.6	%
Mobile and Consumer		115.1			93.7			21.4			22.8	%		223.6			181.5			42.1			23.2	%
Enterprise		91.4			74.0			17.4			23.5	%		167.2			146.4			20.8			14.2	%
Imaging		61.3			43.3			18.0			41.6	%		113.8			82.5			31.3			37.9	%

Total segment revenues	$	417.7		$	332.0			85.7			25.8	%	$	799.8		$	649.2			150.6			23.2	%
Less: acquisition related revenues		(27.4	)		(13.0	)		(14.4	)		110.8	%		(48.8	)		(26.4	)		(22.4	)		84.8	%

Total revenues	$	390.3		$	319.0		$	71.3			22.4	%	$	751.0		$	622.8		$	128.2			20.6	%

Segment Profit
Healthcare	$	69.7		$	57.8			11.9			20.6	%	$	143.7		$	114.6			29.1			25.4	%
Mobile and Consumer		49.7			41.4			8.3			20.0	%		84.6			70.0			14.6			20.9	%
Enterprise		32.6			14.8			17.8			120.3	%		47.7			31.1			16.6			53.4	%
Imaging		28.0			19.0			9.0			47.4	%		48.8			34.8			14.0			40.2	%

Total segment profit	$	180.0		$	133.0		$	47.0			35.3	%	$	324.8		$	250.5		$	74.3			29.7	%

Segment Profit Margin
Healthcare		46.5	%		47.8	%		(1.3	)					48.7	%		48.0	%		0.7
Mobile and Consumer		43.2	%		44.2	%		(1.0	)					37.8	%		38.6	%		(0.8	)
Enterprise		35.7	%		20.0	%		15.7						28.5	%		21.2	%		7.3
Imaging		45.7	%		43.9	%		1.8						42.9	%		42.2	%		0.7

Total segment profit margin		43.1	%		40.1	%		3.0						40.6	%		38.6	%		2.0

Segment Revenue

Three Months Ended March 31, 2012

•

Healthcare segment revenue increased $28.9 million for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, primarily attributable to revenue growth in both licenses and on-demand solutions. Professional services and hosted revenue increased $20.8 million due to growth in on-demand transactional volume, which includes additional volume from our acquisition of Webmedx. Our product and licensing revenue increased $5.6 million driven by continued strength in sales of our Dragon Medical solutions.

•

Mobile and Consumer segment revenue increased $21.4 million for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011. Our product and licensing revenue grew $16.5 million, driven by growth in our embedded handsets. Our professional services and hosting revenue grew $5.9 million, made up of $1.7 million of increase in professional services for embedded solutions and $2.9 million driven primarily by transactional volume growth in our connected mobile services.

•

Enterprise segment revenue increased $17.4 million for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011. Our product and licensing revenue grew $14.2 million, driven primarily by contributions from our acquisition of Loquendo. Our maintenance and support revenue grew $3.5 million from the continued strength in renewals.

•

Imaging segment revenue increased $18.0 million for the three months ended March 31, 2012, as compared to the three months ended March 31, 2011, due to growth in sales from our MFP products driven by our acquisition of Equitrac.

Six Months Ended March 31, 2012

•

Healthcare segment revenue increased $56.4 million, for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, primarily attributable to revenue growth in both licenses and professional services and hosted revenues. Professional services and hosted revenue increased $34.8 million due to growth in on-demand transactional volume, which includes additional volume from our acquisition of Webmedx. Our product and licensing revenue increased $17.0 million driven by continued strength in sales of our Dragon Medical solutions.

•

Mobile and Consumer segment revenue increased $42.1 million for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011. Our product and licensing revenue grew $33.1 million. This is comprised of $26.2 million due to growth in our embedded handset and automotive products, and $6.6 million of growth driven by increased sales of our Dragon Consumer products. Our professional services and hosting revenue grew $10.1 million driven by transactional volume growth in our connected mobile services.

•

Enterprise segment revenue increased $20.8 million for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011. Our product and licensing revenue grew $17.5 million, which includes contributions from our acquisition of Loquendo. Our maintenance and support revenue grew $5.4 million from the continued strength in renewals.

•

Imaging segment revenue increased $31.3 million for the six months ended March 31, 2012, as compared to the six months ended March 31, 2011, due to growth in sales from our MFP products driven by our acquisition of Equitrac.

Segment Profit

Three Months Ended March 31, 2012

•

Healthcare segment profit for the three months ended March 31, 2012 increased 20.6% over the same period last year, driven primarily by segment revenue growth of 23.9%. Segment profit margin decreased 1.3 percentage points, from 47.8% last year to 46.5% during the current period. This decrease was primarily due to a decrease of 3.7 percentage points in margin due to a higher proportion of editing services in our on-demand offerings, offset by improvements in research and development expense of 1.3 percentage points

•

Mobile and Consumer segment profit for the three months ended March 31, 2012 increased 20.0% over the same period last year, resulting in part from a 22.8% increase in segment revenue, partially offset by increased investment in research and development and marketing. Segment profit margin decreased 1.0 percentage points, from 44.2% last year to 43.2% during the period. This decrease was driven primarily by a 3.9 percentage point decrease due to higher research and development expenses to support new product offerings and a 1.2 percentage point decrease as a result of higher marketing demand creation costs to drive Dragon product sales. These impacts were offset by favorable mix of product and licensing revenue, resulting in an increase of 2.5 percentage points.

•

Enterprise segment profit for the three months ended March 31, 2012 increased 120.3% over the same period last year, driven primarily by segment revenue growth of 23.5%. Segment profit margin increased 15.7 percentage points, from 20.0% last year to 35.7% in the current period. This increase benefited from favorable mix of product and licensing revenues, contributing to an increase in gross margins of 11.9 percentage points.

•

Imaging segment profit for the three months ended March 31, 2012 increased 47.4% over the same period last year, resulting in part from segment revenue growth of 41.6%. Segment profit margin increased 1.8 percentage points, from 43.9% last year to 45.7% in the current period. The change in segment profit margin was driven primarily by a 3.0 percentage point improvement due to leveraging of selling expenses. This improvement was offset by increased marketing spend to drive revenue growth and increased research and development expense related to our acquisition of Equitrac, reducing segment profit margin by 1.1 percentage points and 0.6 percentage points, respectively.

Six Months Ended March 31, 2012

•

Healthcare segment profit for the six months ended March 31, 2012 increased 25.4% over the same period last year, driven primarily by segment revenue growth of 23.6%. Segment profit margin improved 0.7 percentage points, from 48.0% last year to 48.7% in the current period. This improvement was driven by operating expense leverage in research and development, selling and marketing expenses which increased the segment profit by 2.8 percentage points, offset by a decrease of 2.1 percentage points in margin due to a higher proportion of editing services in our on-demand offerings.

•

Mobile and Consumer segment profit for the six months ended March 31, 2012 increased 20.9% over the same period last year, resulting in part from a 23.2% increase in segment revenue, partially offset by increased investment in research and development and marketing. Segment profit margin decreased 0.8 percentage points, from 38.6% last year to 37.8% during the period. The change in segment profit margin included a decrease of 3.5 percentage points due to additional investments in research and development to support new product offerings, offset by a 2.3 percentage point improvement resulting from revenue mix shift towards product and licensing revenue.

•

Enterprise segment profit for the six months ended March 31, 2012 increased 53.4% over the same period last year, driven primarily by a 14.2% growth in segment revenue. Segment profit margin increased 7.3 percentage points, from 21.2% last year to 28.5% in the current period. This increase benefited from a favorable mix of product and licensing revenues, contributing to an increase in gross margins of 5.6 percentage points.

•

Imaging segment profit for the six months ended March 31, 2012 increased 40.2% over the same period last year, driven in part from a 37.9% increase in segment revenue offset in part, by increased investment in sales and marketing and research and development expense. Segment profit margin increased 0.7 percentage points, from 42.2% last year to 42.9% during the period. The change in segment profit margin included a 3.1 percentage point improvement due to leveraging selling expenses. This improvement was offset by 2.5 percentage points of segment margin erosion due to increased marketing spend to drive revenue growth and increased research and development expense related to our acquisition of Equitrac, reducing segment profit margin by 0.8 percentage points and 1.7 percentage points, respectively.

LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents totaled $966.7 million as of March 31, 2012, an increase of $519.5 million as compared to $447.2 million as of September 30, 2011. Our working capital was $500.6 million as of March 31, 2012, as compared to $379.9 million as of September 30, 2011. Cash and cash equivalents held by our international operations totaled $72.2 million and $61.7 million at March 31, 2012 and September 30, 2011, respectively. We expect the cash held overseas will continue to be used for our international operations and therefore do not anticipate repatriating these funds. If we were to repatriate these funds, we do not believe that the withholding taxes payable as a result would have a material impact to our liquidity. As of March 31, 2012, our total accumulated deficit was $358.1 million. We do not expect our accumulated deficit to impact our future ability to operate the business given our strong cash and operating cash flow positions, and believe our current cash and cash equivalents and marketable securities on-hand are sufficient to meet our operating needs for at least the next twelve months.

As a result of the trading value of our common stock during the quarter ended March 31, 2012, the 2027 Debentures are convertible at the option of each holder until June 30, 2012, and are therefore classified as a current liability in our balance sheet at March 31, 2012. Based on the current market value of the debentures, we do not anticipate a material portion of the debentures to be converted within the next twelve months.

Cash Provided by Operating Activities

Cash provided by operating activities for the six months ended March 31, 2012 was $190.1 million, an increase of $30.7 million, or 19.3%, as compared to cash provided by operating activities of $159.4 million for the six months ended March 31, 2011. The increase was primarily driven by the following factors:

•

An increase in cash flows of $20.6 million generated by changes in working capital, excluding deferred revenue, primarily driven by an €18.0 million ($23.4 million equivalent) payment during the first quarter of fiscal 2011 for a fixed obligation assumed in connection with our acquisition of SpinVox; and

•

An increase in cash flows of $7.8 million resulting from an increase in net income, exclusive of non-cash adjustment items.

Cash Used in Investing Activities

Cash used in investing activities for the six months ended March 31, 2012 was $137.1 million, an increase of $116.1 million, as compared to cash used in investing activities of $21.0 million for the six months ended March 31, 2011. The net increase in the cash used in investing activities was primarily driven by the following factors:

•

An increase in cash outflows of $109.3 million for business and technology acquisitions, primarily driven by the cash consideration of approximately $77.5 million paid in connection with the acquisition of Swype as well as an advance cash payment of $30.0 million for our pending acquisition of Vlingo during the six months ended March 31, 2012;

•

An increase in cash outflows of $21.2 million resulting from additional capital expenditures, primarily related to the purchase of a corporate asset in the six months ended March 31, 2012;

•

A decrease in cash inflows of $10.4 million from restricted cash related to the release of cash placed in an irrevocable standby letter of credit account which was dispersed upon satisfaction of a liability assumed in connection with our acquisition of SpinVox; and

•

Offset by an increase in cash inflows of $24.9 million related to the purchases and maturities of marketable securities in the periods.

Cash Used in Financing Activities

Cash provided by financing activities for the six months ended March 31, 2012 was $464.6 million, an increase of $482.4 million, as compared to cash used in financing activities of $17.8 million for the six months ended March 31, 2011. The net increase was primarily driven by the following factors:

•

A $676.3 million cash inflow resulting from the issuance of the 2031 Debentures, net of issuance costs, offset by $200.0 million that we used to repurchase 8.5 million shares of our common stock during the quarter ended December 31, 2011;

•

An increase of $9.6 million of cash inflows as the result of the cash received to settle share-based derivatives in the six months ended March 31, 2012 driven by increases in our share price in the period; and

•

Inflows were offset by a $9.7 million increase in cash outflows as a result of higher cash payments required to net share settle employee equity awards, due to an increase in vesting activities and an increase in intrinsic value of the shares vested as a result of the overall increase in our stock price during the six months ended March 31, 2012 as compared to the same period in 2011.

2.75% Convertible Debentures due in 2031

On October 24, 2011, we sold $690 million of 2.75% Convertible Debentures due in 2031 (the “2031 Debentures”) in a private placement pursuant to Rule 144A of the Securities Act of 1933, as amended. Total proceeds, net of debt issuance costs, were $676.6 million. The 2031 Debentures bear interest at 2.75% per year, payable in cash semiannually in arrears, beginning on May 1, 2012. The 2031 Debentures mature on November 1, 2031, subject to the right of the holders to require us to redeem the 2031 Debentures on November 1, 2017, 2021, and 2026. The 2031 Debentures are general senior unsecured obligations and rank equally in right of payment with all of our existing and future unsecured, unsubordinated indebtedness and senior in right of payment to any indebtedness that is contractually subordinated to the 2031 Debentures. The 2031 Debentures will be effectively subordinated to indebtedness and other liabilities of our subsidiaries.

2.75% Convertible Debentures due in 2027

We have $250 million of 2.75% convertible senior debentures due in 2027 (“the 2027 Debentures”) that were issued on August 13, 2007 in a private placement to Citigroup Global Markets Inc. and Goldman, Sachs & Co. The 2027 Debentures bear an interest rate of 2.75% per annum, payable semi-annually in arrears beginning on February 15, 2008, and mature on August 15, 2027 subject to the right of the holders of the 2027 Debentures to require us to redeem the 2027 Debentures on August 15, 2014, 2017 and 2022. The related debt discount and debt issuance costs are being amortized to interest expense using the effective interest rate method

through August 2014. The 2027 Debentures are general senior unsecured obligations, ranking equally in right of payment to all of our existing and future unsecured, unsubordinated indebtedness and senior in right of payment to any indebtedness that is contractually subordinated to the 2027 Debentures. The 2027 Debentures are effectively subordinated to our secured indebtedness to the extent of the value of the collateral securing such indebtedness and are structurally subordinated to indebtedness and other liabilities of our subsidiaries. If converted, the principal amount of the 2027 Debentures is payable in cash and any amounts payable in excess of the $250 million principal amount, will (based on an initial conversion rate, which represents an initial conversion price of approximately $19.47 per share, subject to adjustment as defined therein) be paid in cash or shares of our common stock, at our election, only in the following circumstances and to the following extent: (i) on any date during any fiscal quarter beginning after September 30, 2007 (and only during such fiscal quarter) if the closing sale price of our common stock was more than 120% of the then current conversion price for at least 20 trading days in the period of the 30 consecutive trading days ending on the last trading day of the previous fiscal quarter; (ii) during the five consecutive business-day period following any five consecutive trading-day period in which the trading price for $1,000 principal amount of the Debentures for each day during such five trading-day period was less than 98% of the closing sale price of our common stock multiplied by the then current conversion rate; (iii) upon the occurrence of specified corporate transactions, as described in the indenture for the 2027 Debentures; and (iv) at the option of the holder at any time on or after February 15, 2027. Additionally, we may redeem the 2027 Debentures, in whole or in part, on or after August 20, 2014 at par plus accrued and unpaid interest. Each holder shall have the right, at such holder’s option, to require us to repurchase all or any portion of the 2027 Debentures held by such holder on August 15, 2014, August 15, 2017 and August 15, 2022 at par plus accrued and unpaid interest. Upon conversion, we will pay the principal amount in cash and any amounts payable in excess of the $250 million principal amount will be paid in cash or shares of our common stock, at our election. If we undergo a fundamental change (as described in the indenture for the 2027 Debentures) prior to maturity, holders will have the option to require us to repurchase all or any portion of their debentures for cash at a price equal to 100% of the principal amount of the debentures to be purchased plus any accrued and unpaid interest, including any additional interest to, but excluding, the repurchase date. Our common stock price exceeded the conversion threshold price of $23.36 per share for at least 20 days during the 30 consecutive trading days ended March 31, 2012. Accordingly, the 2027 Debentures are convertible at the holder’s option through June 30, 2012. If the holder were to exercise the conversion option, the principal amount is payable in cash and any amount payable in excess of the $250 million principal amount will be paid in cash or shares of our common stock, at our election. As a result, we have classified the 2027 Debentures in current liabilities as of March 31, 2012 reflecting the redemption rights of the holders to convert their debentures during the quarter ending June 30, 2012.

Credit Facility

Our credit facility consists of a $75 million revolving credit line including letters of credit, a $355 million term loan entered into on March 31, 2006, a $90 million term loan entered into on April 5, 2007 and a $225 million term loan entered into on August 24, 2007 (the “Credit Facility”). In July 2011, we entered into agreements to amend and restate our existing Credit Facility. Of the approximately $638.5 million remaining term loan balance as of July 1, 2011, lenders representing $493.2 million elected to extend the maturity date by three years to March 31, 2016. The remaining $145.3 million in term loans are due March 2013. In addition, lenders participating in the revolving credit facility chose to extend the maturity date by three years to March 31, 2015. As of March 31, 2012, $633.8 million remained outstanding under the term loans, there were $15.5 million of letters of credit issued under the revolving credit line and there were no other outstanding borrowings under the revolving credit line.

Under terms of the amended Credit Facility, interest is payable monthly at a rate equal to the applicable margin plus, at our option, either (a) the base rate which is the higher of the corporate base rate of UBS AG, Stamford Branch, or the federal funds rate plus 0.50% per annum or (b) LIBOR (equal to (i) the British Bankers’ Association Interest Settlement Rates for deposits in U.S. dollars divided by (ii) one minus the statutory reserves applicable to such borrowing). The applicable margin for the borrowings is as follows:


Description	Base Rate Margin	LIBOR Margin
Term loans maturing March 2013	0.75% - 1.50%(a)	1.75% - 2.50%(a)
Term loans maturing March 2016	2.00%	3.00%
Revolving facility due March 2015	1.25% - 2.25%(b)	2.25% - 3.25%(b)

(a)	The margin is determined based on our leverage ratio and credit rating at the date the interest rates are reset on the term loans.

(b)	The margin is determined based on our leverage ratio and credit rating at the date the interest rates are reset on the revolving credit line.

Our obligations under the Credit Facility are unconditionally guaranteed by, subject to certain exceptions, each of our existing and future direct and indirect wholly-owned domestic subsidiaries. The Credit Facility and the guarantees thereof are secured by first priority liens and security interests in the following: 100% of the capital stock of substantially all of our domestic subsidiaries and 65% of the outstanding voting equity interests and 100% of the non-voting equity interests of first-tier foreign subsidiaries, all our material tangible and intangible assets and those of the guarantors, and any present and future intercompany debt. The Credit Facility also contains provisions for mandatory prepayments of outstanding term loans upon receipt of the following, and subject to certain exceptions: 100% of net cash proceeds from asset sales, 100% of net cash proceeds from issuance or incurrence of debt, and 100% of extraordinary receipts. We may voluntarily prepay borrowings under the Credit Facility without premium or penalty other than breakage costs, as defined with respect to LIBOR-based loans.

Off-Balance Sheet Arrangements, Contractual Obligations

Contractual Obligations

The following table outlines our contractual payment obligations as of March 31, 2012 (dollars in millions):


	Payments Due by Fiscal Year Ended September 30,
Contractual Obligations	Total		Remaining 2012		2013 and 2014		2015 and 2016		Thereafter
Credit Facility(1)	$	633.8	$	3.2	$	153.2	$	477.4	$	—
Convertible Senior Debentures(2)		940.0		—		250.0		—		690.0
Interest payable under Credit Facility(1)		63.5		8.1		31.9		23.5		—
Interest payable under 2.75% Convertible Senior Debentures(3)		123.1		12.9		51.7		37.9		20.6
Letters of Credit(4)		15.5		10.9		4.6		—		—
Lease obligations and other liabilities:
Operating leases		138.0		15.3		52.3		41.9		28.5
Other lease obligations associated with the closing of duplicate facilities related to restructurings and acquisitions		1.1		0.5		0.6		—		—
Pension, minimum funding requirement(5)		4.5		1.8		2.7		—		—
Purchase commitments for inventory, property and equipment(6)		9.2		9.2		—		—		—
Collaboration agreements(7)		54.3		23.4		28.4		2.5		—
Other long-term liabilities assumed(8)		13.8		5.3		5.0		3.5		—

Total contractual cash obligations	$	1,996.8	$	90.6	$	580.4	$	586.7	$	739.1

(1)	Interest is due and payable monthly under the Credit Facility, and principal is paid on a quarterly basis. The amounts included as interest payable in this table are based on the effective interest rate as of March 31, 2012 related to the Credit Facility.

(2)

Holders of the 2027 Debentures have the right to require us to repurchase the debentures on August 15, 2014, 2017 and 2022. Holders of the 2031 Debentures have the right to require us to redeem the Debentures on November 1, 2017, 2021, and 2026. As a result of the common stock trigger price provision, each holder of the 2027 Debentures has the right to convert their holdings during the quarter ending June 30, 2012, however we do not believe that a material amount of the holders will elect to convert their Debentures.

(3)	2.75% interest is due and payable semi-annually under 2027 Debentures and 2031 Debentures.

(4)	Letters of Credit are in place primarily to secure future operating lease payments.

(5)	Our U.K. pension plan has a minimum annual funding requirement of £859,900 (approximately $1.4 million based on the exchange rate at March 31, 2012) for each of the next 3 years, through fiscal 2014.

(6)	These amounts include non-cancelable purchase commitments for inventory in the normal course of business to fulfill customers’ orders currently scheduled in our backlog as well as purchase commitments for property and equipment.

(7)	Payments under the research collaboration agreements are payable in cash or common stock at our option.

(8)

Obligations include assumed long-term liabilities relating to restructuring programs initiated by the predecessor companies prior to our acquisition of SpeechWorks International, Inc. in August 2003, and our acquisition of Former Nuance in September 2005. These restructuring programs related to the closing of two facilities with lease terms set to expire in 2016 and 2012, respectively. Total contractual obligations under these two leases are $21.0 million. As of March 31, 2012, we have sub-leased certain of the office space related to these two facilities to unrelated third parties. Total sublease income under contractual terms is expected to be $6.7 million, which ranges from $0.7 million to $1.6 million on an annualized basis through 2016.

The gross liability for unrecognized tax benefits as of March 31, 2012 was $15.4 million. We do not expect a significant change in the amount of unrecognized tax benefits within the next 12 months. We estimate that none of this amount will be paid within the next year and we are currently unable to reasonably estimate the timing of payments for the remainder of the liability.

Contingent Liabilities and Commitments

In connection with certain of our acquisitions, we have agreed to make contingent cash payments to the former shareholders of certain of the acquired companies. The following represents the contingent cash payments that we may be required to make.

In connection with our acquisition of Swype, Inc. in October 2011, we agreed to make deferred payments to the former shareholders of Swype of up to $25.0 million in April 2013, contingent upon the continued employment of three named executives and certain other conditions. The contingent payments will be reduced by amounts specified in the merger agreement in the event that any of the three executives terminates employment prior to the payment date or if any losses occur to which we would be entitled to indemnification under the merger agreement. The portion of the deferred payment that is payable to the three named executives will be recognized as compensation expense over the 18 month employment period. The remaining liability has been recorded at its estimated fair value of $16.4 million.

Pending Acquisitions

In December 2011, we signed an agreement to acquire Vlingo, Inc., subject to regulatory approvals and other customary closing conditions. Pursuant to the terms of the agreement, we have advanced $30.0 million to Vlingo, which is reported in Other Assets at March 31, 2012. We will evaluate the recoverability of any advances each period until the acquisition is completed. Any portion of the advances deemed not recoverable will be expensed as acquisition-related costs, net. In the event that this transaction does not close by July 1, 2012, we are required to make an advance of $5.0 million and will be obligated to pay an additional $5.0 million on the first day of each month thereafter, up to $30.0 million, until the transaction is completed. If the merger agreement is terminated and the transaction does not close, we will expense these non-refundable advances as acquisition-related costs, net.

Off-Balance Sheet Arrangements

Through March 31, 2012, we have not entered into any off-balance sheet arrangements or material transactions with unconsolidated entities or other persons.

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

We are exposed to market risk from changes in foreign currency exchange rates, interest rates and equity prices which could affect operating results, financial position and cash flows. We manage our exposure to these market risks through our regular operating and financing activities and, when appropriate, through the use of derivative financial instruments.

Exchange Rate Sensitivity

We are exposed to changes in foreign currency exchange rates. Any foreign currency transaction, defined as a transaction denominated in a currency other than the U.S. dollar, will be reported in U.S. dollars at the applicable exchange rate. Assets and liabilities are translated into U.S. dollars at exchange rates in effect at the balance sheet date and income and expense items are translated at average rates for the period. The primary foreign currency denominated transactions include revenue and expenses and the resulting accounts receivable and accounts payable balances reflected on our balance sheet. Therefore, the change in the value of the U.S. dollar compared to foreign currencies will have either a positive or negative effect on our financial position and results of operations. Historically, our primary exposure has related to transactions denominated in the euro, British pound, Canadian dollar, Japanese yen, Indian rupee and Hungarian forint.

A hypothetical change of 10% in appreciation or depreciation in foreign currency exchange rates from the quoted foreign currency exchange rates at March 31, 2012 would not have a material impact on our revenue, operating results or cash flows in the coming year.

Periodically, we enter into forward exchange contracts to hedge against foreign currency fluctuations. These contracts may or may not be designated as cash flow hedges for accounting purposes. During fiscal 2011, we established a program that primarily uses

forward contracts to offset the risks associated with foreign currency exposures that arise from transactions denominated in currencies other than the functional currencies of our worldwide operations. We commenced this program so that increases or decreases in our foreign currency exposures are offset by gain or losses on the foreign currency forward contracts. These contracts are not designated as accounting hedges and generally are for periods less than 90 days. The notional contract amount of outstanding foreign currency exchange contracts not designated as cash flow hedges was $99.2 million at March 31, 2012. Based on the nature of the transactions for which the contracts were purchased, a hypothetical change of 10% in exchange rates would not have a material impact on our financial results.

Interest Rate Sensitivity

We are exposed to interest rate risk as a result of our significant cash and cash equivalents, and the outstanding debt under the Credit Facility.

At March 31, 2012, we held approximately $966.7 million of cash and cash equivalents primarily consisting of cash and money-market funds. Due to the low current market yields and the short-term nature of our investments, a hypothetical change in market rates of one percentage point would not have a material effect on the fair value of our portfolio or results of operations.

At March 31, 2012, our total outstanding debt balance exposed to variable interest rates was $633.8 million. A hypothetical change in market rates would have a significant impact on interest expense and amounts payable. Assuming a one percentage point increase in interest rates, our interest expense relative to our outstanding variable rate debt would increase $6.3 million per annum.

Equity Price Risk

We are exposed to equity price risk as a result of security price guarantees that we enter in to from time to time. Generally, these price guarantees are for a period of six months or less, and require payment from either us to a third party, or from the third party to us, based upon changes in our stock price during the contract term. As of March 31, 2012, we had no outstanding security price guarantees.

2027 Debentures

The fair value of our 2027 Debentures is dependent on the price and volatility of our common stock as well as movements in interest rates. The fair market value of the debentures will generally increase or decrease as the market price of our common stock changes. The fair market value of the debentures will generally increase as interest rates fall and decrease as interest rates rise. The market value and interest rate changes affect the fair market value of the debentures, but do not impact our financial position, cash flows or results of operations due to the fixed nature of the debt obligations. However, increases in the value of our common stock above $23.36 for a specified period of time may provide the holders of the debentures the right to convert each bond using a conversion ratio and payment method as defined in the debenture agreement.

Our debentures trade in the financial markets, and the fair value at March 31, 2012 was $365.5 million, based on an average of the bid and ask prices for that day. This compares to a conversion value on March 31, 2012 of approximately $328.5 million. A 10% increase in the stock price over the March 31, 2012 closing price of $25.58 would have an estimated $26.9 million increase to the fair value and a $32.9 million increase to the conversion value of the debentures. Given the current trading value of the debentures, the greatest value to the holders of the debentures would be to sell their holding in the open market in order to maximize their return. Based on this, we believe that the holders may not have a significant economic incentive to convert prior to the first redemption date in August 2014.

2031 Debentures

The fair value of our 2031 Debentures is dependent on the price and volatility of our common stock as well as movements in interest rates. The fair market value of the debentures will generally increase or decrease as the market price of our common stock changes. The fair market value of the debentures will generally increase as interest rates fall and decrease as interest rates rise. The market value and interest rate changes affect the fair market value of the debentures, but do not impact our financial position, cash flows or results of operations due to the fixed nature of the debt obligations. However, increases in the value of our common stock above $41.99 for a specified period of time may provide the holders of the debentures the right to convert each bond using a conversion ratio and payment method as defined in the debenture agreement. Our debentures trade in the financial markets, and the fair value at March 31, 2012 was $784.0 million, based on an average of the bid and ask prices for that day. This compares to a conversion value on March 31, 2012 of approximately $546.5 million. A 10% increase in the stock price over the March 31, 2012 closing price of $25.58 would have an estimated $40.4 million increase to the fair value and a $54.6 million increase to the conversion value of the 2031 Debentures.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15 under the Securities Exchange Act of 1934 (the “Exchange Act”)) designed to ensure that information we are required to disclose in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

We have evaluated the effectiveness of the design and operation of our disclosure controls and procedures under the supervision of, and with the participation of, management, including our Chief Executive Officer and Chief Financial Officer, as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective to meet the requirements of Rule 13a-15 under the Exchange Act.

Changes in internal control over financial reporting

There were no changes to our internal controls over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II. Other Information

Item 1.

Legal Proceedings

This information is included in Note 17, Commitments and Contingencies, in the accompanying notes to consolidated financial statements and is incorporated herein by reference from Item 1 of Part I.

Item 1A.

Risk Factors

You should carefully consider the risks described below when evaluating our company and when deciding whether to invest in our company. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we do not currently believe are important to an investor may also harm our business operations. If any of the events, contingencies, circumstances or conditions described in the following risks actually occurs, our business, financial condition or our results of operations could be seriously harmed. If that happens, the trading price of our common stock could decline and you may lose part or all of the value of any of our shares held by you.

Risks Related to Our Business

Our operating results may fluctuate significantly from period to period, and this may cause our stock price to decline.

Our revenue and operating results have fluctuated in the past and are expected to continue to fluctuate in the future. Given this fluctuation, we believe that quarter to quarter comparisons of revenue and operating results are not necessarily meaningful or an accurate indicator of our future performance. As a result, our results of operations may not meet the expectations of securities analysts or investors in the future. If this occurs, the price of our stock would likely decline. Factors that contribute to fluctuations in operating results include the following:

•

slowing sales by our distribution and fulfillment partners to their customers, which may place pressure on these partners to reduce purchases of our products;

•

volume, timing and fulfillment of customer orders;

•

our ability to generate additional revenue from our intellectual property portfolio;

•

customers delaying their purchasing decisions in anticipation of new versions of our products;

•

customers delaying, canceling or limiting their purchases as a result of the threat or results of terrorism;

•

introduction of new products by us or our competitors;

•

seasonality in purchasing patterns of our customers;

•

reduction in the prices of our products in response to competition, market conditions or contractual obligations;

•

returns and allowance charges in excess of accrued amounts;

•

timing of significant marketing and sales promotions;

•

impairment charges against goodwill and intangible assets;

•

delayed realization of synergies resulting from our acquisitions;

•

write-offs of excess or obsolete inventory and accounts receivable that are not collectible;

•

increased expenditures incurred pursuing new product or market opportunities;

•

general economic trends as they affect retail and corporate sales; and

•

higher than anticipated costs related to fixed-price contracts with our customers.

Due to the foregoing factors, among others, our revenue and operating results are difficult to forecast. Our expense levels are based in significant part on our expectations of future revenue and we may not be able to reduce our expenses quickly to respond to a shortfall in projected revenue. Therefore, our failure to meet revenue expectations would seriously harm our operating results, financial condition and cash flows.

We have grown, and may continue to grow, through acquisitions, which could dilute our existing stockholders.

As part of our business strategy, we have in the past acquired, and expect to continue to acquire, other businesses and technologies. In connection with past acquisitions, we issued a substantial number of shares of our common stock as transaction consideration and also incurred significant debt to finance the cash consideration used for our acquisitions. We may continue to issue equity securities for future acquisitions, which would dilute existing stockholders, perhaps significantly depending on the terms of such acquisitions. We may also incur additional debt in connection with future acquisitions, which, if available at all, may place additional restrictions on our ability to operate our business.

Our ability to realize the anticipated benefits of our acquisitions will depend on successfully integrating the acquired businesses.

Our prior acquisitions required, and our recently completed acquisitions continue to require, substantial integration and management efforts and we expect future acquisitions to require similar efforts. Acquisitions of this nature involve a number of risks, including:

•

difficulty in transitioning and integrating the operations and personnel of the acquired businesses;

•

potential disruption of our ongoing business and distraction of management;

•

potential difficulty in successfully implementing, upgrading and deploying in a timely and effective manner new operational information systems and upgrades of our finance, accounting and product distribution systems;

•

difficulty in incorporating acquired technology and rights into our products and technology;

•

potential difficulties in completing projects associated with in-process research and development;

•

unanticipated expenses and delays in completing acquired development projects and technology integration;

•

management of geographically remote business units both in the United States and internationally;

•

impairment of relationships with partners and customers;

•

assumption of unknown material liabilities of acquired companies;

•

accurate projection of revenue plans of the acquired entity in the due diligence process;

•

customers delaying purchases of our products pending resolution of product integration between our existing and our newly acquired products;

•

entering markets or types of businesses in which we have limited experience; and

•

potential loss of key employees of the acquired business.

As a result of these and other risks, if we are unable to successfully integrate acquired businesses, we may not realize the anticipated benefits from our acquisitions. Any failure to achieve these benefits or failure to successfully integrate acquired businesses and technologies could seriously harm our business.

Charges to earnings as a result of our acquisitions may adversely affect our operating results in the foreseeable future, which could have a material and adverse effect on the market value of our common stock.

Under accounting principles generally accepted in the United States of America, we record the market value of our common stock or other form of consideration issued in connection with an acquisition as the cost of acquiring the company or business. We have allocated that cost to the individual assets acquired and liabilities assumed, including various identifiable intangible assets such as acquired technology, acquired trade names and acquired customer relationships based on their respective fair values. Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain. After we complete an acquisition, the following factors could result in material charges and adversely affect our operating results and may adversely affect our cash flows:

•

costs incurred to combine the operations of businesses we acquire, such as transitional employee expenses and employee retention, redeployment or relocation expenses;

•

impairment of goodwill or intangible assets;

•

amortization of intangible assets acquired;

•

a reduction in the useful lives of intangible asset acquired;

•

identification of or changes to assumed contingent liabilities, both income tax and non-income tax related after our final determination of the amounts for these contingencies or the conclusion of the measurement period (generally up to one year from the acquisition date), whichever comes first;

•

charges to our operating results to eliminate certain duplicative pre-merger activities, to restructure our operations or to reduce our cost structure;

•

charges to our operating results resulting from expenses incurred to effect the acquisition; and

•

charges to our operating results due to the expensing of certain stock awards assumed in an acquisition.

Intangible assets are generally amortized over a five to fifteen year period. Goodwill and certain intangible assets with indefinite lives, are not subject to amortization but are subject to an impairment analysis, at least annually, which may result in an impairment charge if the carrying value exceeds its implied fair value. As of March 31, 2012, we had identified intangible assets of approximately $693.9 million, net of accumulated amortization, and goodwill of approximately $2.4 billion. In addition, purchase accounting limits

our ability to recognize certain revenue that otherwise would have been recognized by the acquired company as an independent business. As a result, the combined company may delay revenue recognition or recognize less revenue than we and the acquired company would have recognized as independent companies.

Our significant debt could adversely affect our financial health and prevent us from fulfilling our obligations under our credit facility and our convertible debentures.

We have a significant amount of debt. As of March 31, 2012, we had a total of $1,574.0 million of gross debt outstanding, including $144.3 million in term loans due in March 2013, $489.5 million in term loans due in March 2016 under an amended and restated agreement signed in July 2011, and $940.0 million in convertible debentures. Investors may convert the 2027 Debentures, totaling $250.0 million in aggregate principal amount during the quarter ending June 30, 2012 because our common stock price exceeded 120% of the conversion price of approximately $23.36 per share for certain specified periods. If a holder elects to convert, we will be required to pay the principal amount in cash and any amounts payable in excess of the principal amount will be paid in cash or shares of our common stock, at our election. In addition, investors may require us to redeem the 2027 Debentures in August 2014. Investors may require us to redeem the 2031 Debentures, totaling $690.0 million in aggregate principal amount in November 2017, or sooner if our common stock price exceeds the conversion price of approximately $32.30 per share for certain specified periods. We also have a $75.0 million revolving credit line available to us through March 2015. As of March 31, 2012, there were $15.5 million of letters of credit issued but there were no other outstanding borrowings under the revolving credit line. Our debt level could have important consequences, for example it could:

•

require us to use a large portion of our cash flow to pay principal and interest on debt, including the convertible debentures and the credit facility, which will reduce the availability of our cash flow to fund working capital, capital expenditures, acquisitions, research and development expenditures and other business activities;

•

restrict us from making strategic acquisitions or exploiting business opportunities;

•

place us at a competitive disadvantage compared to our competitors that have less debt; and

•

limit, along with the financial and other restrictive covenants related to our debt, our ability to borrow additional funds, dispose of assets or pay cash dividends.

Our ability to meet our payment and other obligations under our debt instruments depends on our ability to generate significant cash flow in the future. This, to some extent, is subject to general economic, financial, competitive, legislative and regulatory factors as well as other factors that are beyond our control. We cannot assure you that our business will generate cash flow from operations, or that additional capital will be available to us, in an amount sufficient to enable us to meet our payment obligations under the convertible debentures and our other debt and to fund other liquidity needs. If we are not able to generate sufficient cash flow to service our debt obligations, we may need to refinance or restructure our debt, including the convertible debentures, sell assets, reduce or delay capital investments, or seek to raise additional capital. If we are unable to implement one or more of these alternatives, we may not be able to meet our payment obligations under the convertible debentures and our other debt.

In addition, a substantial portion of our debt bears interest at variable rates. If market interest rates increase, our debt service requirements will increase, which would adversely affect our results of operations and cash flows.

Our debt agreements contain covenant restrictions that may limit our ability to operate our business.

The agreement governing our senior credit facility contains, and any of our other future debt agreements may contain, covenant restrictions that limit our ability to operate our business, including restrictions on our ability to:

•

incur additional debt or issue guarantees;

•

create liens;

•

make certain investments;

•

enter into transactions with our affiliates;

•

sell certain assets;

•

redeem capital stock or make other restricted payments;

•

declare or pay dividends or make other distributions to stockholders; and

•

merge or consolidate with any entity.

Our ability to comply with these covenants is dependent on our future performance, which will be subject to many factors, some of which are beyond our control, including prevailing economic conditions. As a result of these covenants, our ability to respond to changes in business and economic conditions and to obtain additional financing, if needed, may be significantly restricted, and we may be prevented from engaging in transactions that might otherwise be beneficial to us. In addition, our failure to comply with these covenants could result in a default under our debt agreements, which could permit the holders to accelerate our obligation to repay the debt. If any of our debt is accelerated, we may not have sufficient funds available to repay the accelerated debt.

We have a history of operating losses, and may incur losses in the future, which may require us to raise additional capital on unfavorable terms.

We reported net income of $38.2 million in fiscal 2011; however we reported net losses of $19.1 million and $19.4 million for the fiscal years 2010 and 2009, respectively. If we are unable to maintain profitability, the market price for our stock may decline, perhaps substantially. We cannot assure you that our revenue will grow or that we will maintain profitability in the future. If we do not achieve and maintain profitability, we may be required to raise additional capital to maintain or grow our operations. Additional capital, if available at all, may be highly dilutive to existing investors or contain other unfavorable terms, such as a high interest rate and restrictive covenants.

Voice and language technologies may not continue to garner widespread acceptance, which could limit our ability to grow our voice and language business.

We have invested and expect to continue to invest heavily in the acquisition, development and marketing of voice and language technologies. The market for voice and language technologies is relatively new and rapidly evolving. Our ability to increase revenue in the future depends in large measure on the continuing acceptance of these technologies in general and our products in particular. The continued development of the market for our current and future voice and language solutions in general, and our solutions in particular, will also depend on:

•

consumer and business demand for speech-enabled applications;

•

development by third-party vendors of applications using voice and language technologies; and

•

continuous improvement in voice and language technology.

Sales of our voice and language products would be harmed if the market for these technologies does not continue to increase or increases slower than we expect, or if we fail to develop new technology faster than our competitors, and consequently, our business could be harmed and we may not achieve a level of profitability necessary to successfully operate our business.

The markets in which we operate are highly competitive and rapidly changing and we may be unable to compete successfully.

There are a number of companies that develop or may develop products that compete in our targeted markets. The individual markets in which we compete are highly competitive, and are rapidly changing. Within voice and language, we compete with AT&T, Microsoft, Google, and other smaller providers. Within healthcare, we compete with M*Modal and other smaller providers. Within imaging, we compete with ABBYY, Adobe, I.R.I.S. and NewSoft. In voice and language, some of our partners such as Avaya, Cisco, Intervoice and Genesys develop and market products that can be considered substitutes for our solutions. In addition, a number of smaller companies in voice, language and imaging produce technologies or products that are in some markets competitive with our solutions. Current and potential competitors have established, or may establish, cooperative relationships among themselves or with third parties to increase the ability of their technologies to address the needs of our prospective customers.

The competition in these markets could adversely affect our operating results by reducing the volume of the products we license or the prices we can charge. Some of our current or potential competitors, such as Adobe, Microsoft and Google, have significantly greater financial, technical and marketing resources than we do. These competitors may be able to respond more rapidly than we can to new or emerging technologies or changes in customer requirements. They may also devote greater resources to the development, promotion and sale of their products than we do.

Some of our customers, such as Microsoft and Google, have developed or acquired products or technologies that compete with our products and technologies. These customers may give higher priority to the sale of these competitive products or technologies. To the extent they do so, market acceptance and penetration of our products, and therefore our revenue, may be adversely affected. Our success will depend substantially upon our ability to enhance our products and technologies and to develop and introduce, on a timely and cost-effective basis, new products and features that meet changing customer requirements and incorporate technological enhancements. If we are unable to develop new products and enhance functionalities or technologies to adapt to these changes, or if we are unable to realize synergies among our acquired products and technologies, our business will suffer.

The failure to successfully maintain the adequacy of our system of internal control over financial reporting could have a material adverse impact on our ability to report our financial results in an accurate and timely manner.

The SEC, as directed by Section 404 of the Sarbanes-Oxley Act of 2002, adopted rules requiring public companies to include a report of management on internal control over financial reporting in their annual reports on Form 10-K that contains an assessment by management of the effectiveness of our internal control over financial reporting. In addition, our independent registered public accounting firm must attest to and report on the effectiveness of our internal control over financial reporting. Any failure in the effectiveness of our system of internal control over financial reporting could have a material adverse impact on our ability to report

our financial statements in an accurate and timely manner, could subject us to regulatory actions, civil or criminal penalties, shareholder litigation, or loss of customer confidence, which could result in an adverse reaction in the financial marketplace due to a loss of investor confidence in the reliability of our financial statements, which ultimately could negatively impact our stock price.

A significant portion of our revenue is derived, and a significant portion of our research and development activities are based, outside the United States. Our results could be harmed by economic, political, regulatory and other risks associated with these international regions.

Because we operate worldwide, our business is subject to risks associated with doing business internationally. We anticipate that revenue from international operations could increase in the future. Most of our international revenue is generated by sales in Europe and Asia. In addition, some of our products are developed and manufactured outside the United States and we have a large number of employees in India that provide transcription services. We also have a large number of employees in Canada and United Kingdom that provide professional services. A significant portion of the development and manufacturing of our voice and language products is conducted in Belgium and Canada, and a significant portion of our imaging research and development is conducted in Hungary. We also have significant research and development resources in Austria, Germany, Italy, and United Kingdom. Accordingly, our future results could be harmed by a variety of factors associated with international sales and operations, including:

•

changes in a specific country’s or region’s economic conditions;

•

geopolitical turmoil, including terrorism and war;

•

trade protection measures and import or export licensing requirements imposed by the United States or by other countries;

•

compliance with foreign and domestic laws and regulations;

•

negative consequences from changes in applicable tax laws;

•

difficulties in staffing and managing operations in multiple locations in many countries;

•

difficulties in collecting trade accounts receivable in other countries; and

•

less effective protection of intellectual property than in the United States.

We are exposed to fluctuations in foreign currency exchange rates.

Because we have international subsidiaries and distributors that operate and sell our products outside the United States, we are exposed to the risk of changes in foreign currency exchange rates. In certain circumstances, we have entered into forward exchange contracts to hedge against foreign currency fluctuations. We use these contracts to reduce our risk associated with exchange rate movements, as the gains or losses on these contracts are intended to offset any exchange rate losses or gains on the hedged transaction. We do not engage in foreign currency speculation. With our increased international presence in a number of geographic locations and with international revenue and costs projected to increase, we are exposed to changes in foreign currencies including the euro, British pound, Canadian dollar, Japanese yen, Indian rupee, Australian dollar, Israel shekel, Swiss franc and the Hungarian forint. Changes in the value of foreign currencies relative to the value of the U.S. dollar could adversely affect future revenue and operating results.

Impairment of our intangible assets could result in significant charges that would adversely impact our future operating results.

We have significant intangible assets, including goodwill and intangibles with indefinite lives, which are susceptible to valuation adjustments as a result of changes in various factors or conditions. The most significant intangible assets are patents and core technology, completed technology, customer relationships and trademarks. Customer relationships are amortized on an accelerated basis based upon the pattern in which the economic benefits of customer relationships are being utilized. Other identifiable intangible assets are amortized on a straight-line basis over their estimated useful lives. We assess the potential impairment of intangible assets on an annual basis, as well as whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors that could trigger an impairment of such assets, include the following:

•

significant underperformance relative to historical or projected future operating results;

•

significant changes in the manner of or use of the acquired assets or the strategy for our overall business;

•

significant negative industry or economic trends;

•

significant decline in our stock price for a sustained period;

•

changes in our organization or management reporting structure that could result in additional reporting units, which may require alternative methods of estimating fair values or greater disaggregation or aggregation in our analysis by reporting unit; and

•

a decline in our market capitalization below net book value.

Future adverse changes in these or other unforeseeable factors could result in an impairment charge that would impact our results of operations and financial position in the reporting period identified.

Our sales to government clients subject us to risks, including early termination, audits, investigations, sanctions and penalties.

We derive a portion of our revenues from contracts with the United States government, as well as various state and local governments, and their respective agencies. Government contracts are generally subject to audits and investigations which could identify violations of these agreements. Government contract violations could result in a range of consequences including, but not limited to, contract price adjustments, civil and criminal penalties, contract termination, forfeiture of profit and/or suspension of payment, and suspension or debarment from future government contracts. We could also suffer serious harm to our reputation if we were found to have violated the terms of our government contracts.

We conducted an analysis of our compliance with the terms and conditions of certain contracts with the U.S. General Services Administration (“GSA”). Based upon our analysis, we voluntarily notified GSA of non-compliance with the terms of two contracts. The final resolution of this matter may adversely impact our financial position.

If we are unable to attract and retain key personnel, our business could be harmed.

If any of our key employees were to leave, we could face substantial difficulty in hiring qualified successors and could experience a loss in productivity while any successor obtains the necessary training and experience. Our employment relationships are generally at-will and we have had key employees leave in the past. We cannot assure you that one or more key employees will not leave in the future. We intend to continue to hire additional highly qualified personnel, including software engineers and operational personnel, but may not be able to attract, assimilate or retain qualified personnel in the future. Any failure to attract, integrate, motivate and retain these employees could harm our business.

Our medical transcription services may be subject to legal claims for failure to comply with laws governing the confidentiality of medical records.

Healthcare professionals who use our medical transcription services deliver to us health information about their patients including information that constitutes a record under applicable law that we may store on our computer systems. Numerous federal and state laws and regulations, the common law and contractual obligations govern collection, dissemination, use and confidentiality of patient-identifiable health information, including:

•

state and federal privacy and confidentiality laws;

•

our contracts with customers and partners;

•

state laws regulating healthcare professionals;

•

Medicaid laws; and

•

the Health Insurance Portability and Accountability Act of 1996 and related rules proposed by the Health Care Financing Administration.

The Health Insurance Portability and Accountability Act of 1996 establishes elements including, but not limited to, federal privacy and security standards for the use and protection of protected health information. Any failure by us or by our personnel or partners to comply with applicable requirements may result in a material liability. Although we have systems and policies in place for safeguarding protected health information from unauthorized disclosure, these systems and policies may not preclude claims against us for alleged violations of applicable requirements. There can be no assurance that we will not be subject to liability claims that could have a material adverse affect on our business, results of operations and financial condition.

Adverse changes in general economic or political conditions in any of the major countries in which we do business could adversely affect our operating results.

Adverse changes in domestic and global economic and political conditions, as well as uncertainty in the global financial markets may negatively affect our financial results. These macroeconomic developments could negatively affect our business, operating results or financial condition in a number of ways which, in turn, could adversely affect our stock price. A prolonged period of economic decline could have a material adverse effect on our results of operations and financial condition and exacerbate some of the other risk factors described herein. Our customers may defer purchases of our products, licenses, and services in response to tighter credit and negative financial news or reduce their demand for them. Our customers may also not be able to obtain adequate access to credit, which could affect their ability to make timely payments to us or ultimately cause the customer to file for protection from creditors under applicable insolvency or bankruptcy laws. If our customers are not able to make timely payments to us, our accounts receivable could increase. Political instability in any of the major countries in which we do business would also likely harm our business, results of operations and financial condition.

Current uncertainty in the global financial markets and the global economy may negatively affect our financial results.

Our investment portfolio, which includes short-term debt securities, is generally subject to credit, liquidity, counterparty, market and interest rate risks that may be exacerbated by the recent global financial crisis. If the banking system or the fixed income, credit or equity markets deteriorate or remain volatile, our investment portfolio may be impacted and the values and liquidity of our investments could be adversely affected.

In addition, our operating results and financial condition could be negatively affected if, as a result of economic conditions, either:

•

the demand for, and prices of, our products, licenses, or services are reduced as a result of actions by our competitors or otherwise; or

•

our financial counterparties or other contractual counterparties are unable to, or do not, meet their contractual commitments to us.

Security and privacy breaches in our systems may damage client relations and inhibit our growth.

The uninterrupted operation of our hosted solutions and the confidentiality and security of third-party information is critical to our business. Any failures in our security and privacy measures could have a material adverse effect on our financial position and results of operations. If we are unable to protect, or our clients perceive that we are unable to protect, the security and privacy of our electronic information, our growth could be materially adversely affected. A security or privacy breach may:

•

cause our clients to lose confidence in our solutions;

•

harm our reputation;

•

expose us to liability; and

•

increase our expenses from potential remediation costs.

While we believe we use proven applications designed for data security and integrity to process electronic transactions, there can be no assurance that our use of these applications will be sufficient to address changing market conditions or the security and privacy concerns of existing and potential clients.

Risks Related to Our Intellectual Property and Technology

Unauthorized use of our proprietary technology and intellectual property could adversely affect our business and results of operations.

Our success and competitive position depend in large part on our ability to obtain and maintain intellectual property rights protecting our products and services. We rely on a combination of patents, copyrights, trademarks, service marks, trade secrets, confidentiality provisions and licensing arrangements to establish and protect our intellectual property and proprietary rights. Unauthorized parties may attempt to copy aspects of our products or to obtain, license, sell or otherwise use information that we regard as proprietary. Policing unauthorized use of our products is difficult and we may not be able to protect our technology from unauthorized use. Additionally, our competitors may independently develop technologies that are substantially the same or superior to our technologies and that do not infringe our rights. In these cases, we would be unable to prevent our competitors from selling or licensing these similar or superior technologies. In addition, the laws of some foreign countries do not protect our proprietary rights to the same extent as the laws of the United States. Although the source code for our proprietary software is protected both as a trade secret and as a copyrighted work, litigation may be necessary to enforce our intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others, or to defend against claims of infringement or invalidity. Litigation, regardless of the outcome, can be very expensive and can divert management efforts.

Third parties have claimed and may claim in the future that we are infringing their intellectual property, and we could be exposed to significant litigation or licensing expenses or be prevented from selling our products if such claims are successful.

From time to time, we are subject to claims that we or our customers may be infringing or contributing to the infringement of the intellectual property rights of others. We may be unaware of intellectual property rights of others that may cover some of our technologies and products. If it appears necessary or desirable, we may seek licenses for these intellectual property rights. However, we may not be able to obtain licenses from some or all claimants, the terms of any offered licenses may not be acceptable to us, and we may not be able to resolve disputes without litigation. Any litigation regarding intellectual property could be costly and time-consuming and could divert the attention of our management and key personnel from our business operations. In the event of a claim of intellectual property infringement, we may be required to enter into costly royalty or license agreements. Third parties claiming intellectual property infringement may be able to obtain injunctive or other equitable relief that could effectively block our ability to develop and sell our products.

We may incur substantial costs enforcing or acquiring intellectual property rights and defending against third-party claims as a result of litigation or other proceedings.

In connection with the enforcement of our own intellectual property rights, the acquisition of third-party intellectual property rights, or disputes relating to the validity or alleged infringement of third-party intellectual property rights, including patent rights, we have been, are currently, and may in the future be, subject to claims, negotiations or complex, protracted litigation. Intellectual property disputes and litigation are typically very costly and can be disruptive to our business operations by diverting the attention and energy of management and key technical personnel. Although we have successfully defended or resolved past litigation and disputes, we may not prevail in any ongoing or future litigation and disputes. In addition, we may incur significant costs in acquiring the necessary third party intellectual property rights for use in our products. Third party intellectual property disputes could subject us to significant liabilities, require us to enter into royalty and licensing arrangements on unfavorable terms, prevent us from manufacturing or licensing certain of our products, cause severe disruptions to our operations or the markets in which we compete, or require us to satisfy indemnification commitments with our customers including contractual provisions under various license arrangements. Any of these could seriously harm our business.

Our software products may have bugs, which could result in delayed or lost revenue, expensive correction, liability to our customers and claims against us.

Complex software products such as ours may contain errors, defects or bugs. Defects in the solutions or products that we develop and sell to our customers could require expensive corrections and result in delayed or lost revenue, adverse customer reaction and negative publicity about us or our products and services. Customers who are not satisfied with any of our products may also bring claims against us for damages, which, even if unsuccessful, would likely be time-consuming to defend, and could result in costly litigation and payment of damages. Such claims could harm our reputation, financial results and competitive position.

Risks Related to our Corporate Structure, Organization and Common Stock

The holdings of our largest stockholder may enable it to influence matters requiring stockholder approval.

As of March 31, 2012, Warburg Pincus, a global private equity firm, beneficially owned approximately 19% of our outstanding common stock, including warrants exercisable for up to 3,862,422 shares of our common stock, and 3,562,238 shares of our outstanding Series B Preferred Stock, each of which is convertible into one share of our common stock. Because of its large holdings of our capital stock relative to other stockholders, this stockholder has a strong influence over matters requiring approval by our stockholders.

The market price of our common stock has been and may continue to be subject to wide fluctuations, and this may make it difficult for you to resell the common stock when you want or at prices you find attractive.

Our stock price historically has been, and may continue to be, volatile. Various factors contribute to the volatility of our stock price, including, for example, quarterly variations in our financial results, new product introductions by us or our competitors and general economic and market conditions. Sales of a substantial number of shares of our common stock by our largest stockholders, or the perception that such sales could occur, could also contribute to the volatility or our stock price. While we cannot predict the individual effect that these factors may have on the market price of our common stock, these factors, either individually or in the aggregate, could result in significant volatility in our stock price during any given period of time. Moreover, companies that have experienced volatility in the market price of their stock often are subject to securities class action litigation. If we were the subject of such litigation, it could result in substantial costs and divert management’s attention and resources.

Compliance with changing regulation of corporate governance and public disclosure may result in additional expenses.

Changing laws, regulations and standards relating to corporate governance and public disclosure, including the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, new regulations promulgated by the Securities and Exchange Commission and the rules of the Nasdaq Marketplace, are resulting in increased general and administrative expenses for companies such as ours. These new or changed laws, regulations and standards are subject to varying interpretations in many cases, and as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies, which could result in higher costs necessitated by ongoing revisions to disclosure and governance practices. We are committed to maintaining high standards of corporate governance and public disclosure. As a result, we intend to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new or changed laws, regulations and standards differ from the activities intended by regulatory or governing bodies, our business may be harmed.

Future sales of our common stock in the public market could adversely affect the trading price of our common stock and our ability to raise funds in new stock offerings.

Future sales of substantial amounts of our common stock in the public market, or the perception that such sales could occur, could adversely affect prevailing trading prices of our common stock and could impair our ability to raise capital through future offerings of equity or equity-related securities. In connection with past acquisitions, we issued a substantial number of shares of our common stock as transaction consideration. We may continue to issue equity securities for future acquisitions, which would dilute existing stockholders, perhaps significantly depending on the terms of such acquisitions. No prediction can be made as to the effect, if any, that future sales of shares of common stock, or the availability of shares of common stock for future sale, will have on the trading price of our common stock.

We have implemented anti-takeover provisions, which could discourage or prevent a takeover, even if an acquisition would be beneficial to our stockholders.

Provisions of our certificate of incorporation, bylaws and Delaware law, as well as other organizational documents could make it more difficult for a third party to acquire us, even if doing so would be beneficial to our stockholders. These provisions include:

•

authorized “blank check” preferred stock;

•

prohibiting cumulative voting in the election of directors;

•

limiting the ability of stockholders to call special meetings of stockholders;

•

requiring all stockholder actions to be taken at meetings of our stockholders; and

•

establishing advance notice requirements for nominations of directors and for stockholder proposals.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

None.

Item 6.

Exhibits

The exhibits listed on the Exhibit Index are filed or incorporated by reference (as stated therein) as part of this Quarterly Report on Form 10-Q.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Burlington, Commonwealth of Massachusetts, on May 10, 2012.


Nuance Communications, Inc.

By:		/s/ Thomas L. Beaudoin
		Thomas L. Beaudoin
		Executive Vice President and Chief Financial Officer

EXHIBIT INDEX

Incorporated by Reference

Exhibit

Number

Exhibit Description

Form

File No.

Exhibit

Filing

Date

Filed

Herewith

2.1

Agreement and Plan of Merger, dated as of March 6, 2012, by and among Nuance, Townsend Merger Corporation, a wholly owned subsidiary of Nuance, and Transcend Services, Inc..

8-K

0-27038

2.1

3/7/2012

3.1

Amended and Restated Certificate of Incorporation of the Registrant.

10-Q

0-27038

3.2

5/11/2001

3.2

Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Registrant.

10-Q

0-27038

3.1

8/9/2004

3.3

Certificate of Ownership and Merger.

8-K

0-27038

3.1

10/19/2005

3.4

Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Registrant.

S-3

333-142182

3.3

4/18/2007

3.5

Amended and Restated Bylaws of the Registrant.

10-K

0-27038

3.2

3/15/2004

31.1

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or 15d-14(a).

31.2

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or 15d-14(a).

32.1

Certification Pursuant to 18 U.S.C. Section 1350.

101

The following materials from Nuance Communications, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Balance Sheets, (iii) the Consolidated Statements of Cash Flows, and (iv) Notes of Consolidated Financial Statements.